<html>
    <head>
        <meta charset="utf-8">
        
            <script src="lib/bindings/utils.js"></script>
            <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/dist/vis-network.min.css" integrity="sha512-WgxfT5LWjfszlPHXRmBWHkV2eceiWTOBvrKCNbdgDYTHrT2AeLCGbF4sZlZw3UMN3WtL0tGUoIAKsu8mllg/XA==" crossorigin="anonymous" referrerpolicy="no-referrer" />
            <script src="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/vis-network.min.js" integrity="sha512-LnvoEWDFrqGHlHmDD2101OrLcbsfkrzoSpvtSQtxK3RMnRV0eOkhhBN2dXHKRrUU8p2DGRTk35n4O8nWSVe1mQ==" crossorigin="anonymous" referrerpolicy="no-referrer"></script>
            
        
<center>
<h1></h1>
</center>

<!-- <link rel="stylesheet" href="../node_modules/vis/dist/vis.min.css" type="text/css" />
<script type="text/javascript" src="../node_modules/vis/dist/vis.js"> </script>-->
        <link
          href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/css/bootstrap.min.css"
          rel="stylesheet"
          integrity="sha384-eOJMYsd53ii+scO/bJGFsiCZc+5NDVN2yr8+0RDqr0Ql0h+rP48ckxlpbzKgwra6"
          crossorigin="anonymous"
        />
        <script
          src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/js/bootstrap.bundle.min.js"
          integrity="sha384-JEW9xMcG8R+pH31jmWH6WWP0WintQrMb4s7ZOdauHnUtxwoG2vI5DkLtS3qm9Ekf"
          crossorigin="anonymous"
        ></script>


        <center>
          <h1></h1>
        </center>
        <style type="text/css">

             #mynetwork {
                 width: 100%;
                 height: 100%;
                 background-color: #ffffff;
                 border: 1px solid lightgray;
                 position: relative;
                 float: left;
             }

             
             #loadingBar { display: none !important; 
                 position:absolute;
                 top:0px;
                 left:0px;
                 width: 100%;
                 height: 100%;
                 background-color:rgba(200,200,200,0.8);
                 -webkit-transition: all 0.5s ease;
                 -moz-transition: all 0.5s ease;
                 -ms-transition: all 0.5s ease;
                 -o-transition: all 0.5s ease;
                 transition: all 0.5s ease;
                 opacity:1;
             }

             #bar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width:20px;
                 height:20px;
                 margin:auto auto auto auto;
                 border-radius:11px;
                 border:2px solid rgba(30,30,30,0.05);
                 background: rgb(0, 173, 246); /* Old browsers */
                 box-shadow: 2px 0px 4px rgba(0,0,0,0.4);
             }

             #border {
                 position:absolute;
                 top:10px;
                 left:10px;
                 width:500px;
                 height:23px;
                 margin:auto auto auto auto;
                 box-shadow: 0px 0px 4px rgba(0,0,0,0.2);
                 border-radius:10px;
             }

             #text {
                 position:absolute;
                 top:8px;
                 left:530px;
                 width:30px;
                 height:50px;
                 margin:auto auto auto auto;
                 font-size:22px;
                 color: #000000;
             }

             div.outerBorder {
                 position:relative;
                 top:400px;
                 width:600px;
                 height:44px;
                 margin:auto auto auto auto;
                 border:8px solid rgba(0,0,0,0.1);
                 background: rgb(252,252,252); /* Old browsers */
                 background: -moz-linear-gradient(top,  rgba(252,252,252,1) 0%, rgba(237,237,237,1) 100%); /* FF3.6+ */
                 background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,rgba(252,252,252,1)), color-stop(100%,rgba(237,237,237,1))); /* Chrome,Safari4+ */
                 background: -webkit-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Chrome10+,Safari5.1+ */
                 background: -o-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Opera 11.10+ */
                 background: -ms-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* IE10+ */
                 background: linear-gradient(to bottom,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* W3C */
                 filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#fcfcfc', endColorstr='#ededed',GradientType=0 ); /* IE6-9 */
                 border-radius:72px;
                 box-shadow: 0px 0px 10px rgba(0,0,0,0.2);
             }
             

             

             
        </style>
    </head>


    <body>
        <div class="card" style="width: 100%">
            
            
            <style>
/* Container-based layout - flexible sizing */
#citation-network-container {
    position: relative;
    width: 100%;
    height: 100%;
    min-height: 400px;
    border: 1px solid #ccc;
    overflow: hidden;
    background: #fff;
}

#filter-panel {
    width: 300px;
    background: white;
    border: 1px solid #ccc;
    border-radius: 8px;
    padding: 15px;
    max-height: 70vh;
    overflow-y: auto;
    display: none;
    position: absolute;
    top: 50px;
    right: 10px;
    z-index: 1002;
}

#filter-panel.show {
    display: block;
}

#legend-panel {
    position: absolute;
    bottom: 10px;
    left: 10px;
    width: auto;
    max-width: 200px;
    background: white;
    border: 1px solid #ccc;
    border-radius: 8px;
    padding: 12px;
    z-index: 1000;
    font-size: 12px;
}

#title-panel {
    position: absolute;
    top: 10px;
    left: 10px;
    width: auto;
    max-width: 550px;
    background: white;
    border: 1px solid #ccc;
    border-radius: 8px;
    padding: 15px 20px;
    z-index: 1000;
    text-align: left;
}

#title-panel h1 {
    margin: 0 0 5px 0;
    font-size: 18px;
    font-weight: bold;
    color: #333;
}

#title-panel h2 {
    margin: 0;
    font-size: 14px;
    font-weight: normal;
    color: #666;
}

.filter-group {
    margin-bottom: 15px;
}

.filter-group label {
    display: block;
    font-weight: bold;
    margin-bottom: 8px;
    color: #333;
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
}

.checkbox-group {
    max-height: 150px;
    overflow-y: auto;
    border: 1px solid #ccc;
    border-radius: 8px;
    padding: 10px;
    background: white;
}

.checkbox-group.two-column {
    display: grid;
    grid-template-columns: 1fr 1fr;
    gap: 5px;
}

.checkbox-item {
    display: flex;
    align-items: center;
    margin-bottom: 6px;
    font-size: 14px;
    line-height: 1.3;
}

.checkbox-item input[type="checkbox"] {
    margin-right: 8px;
    margin-top: 0;
    margin-bottom: 0;
    transform: scale(1.1);
    flex-shrink: 0;
}

.checkbox-item label {
    cursor: pointer;
    margin: 0;
    font-weight: normal;
    color: #333;
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
}

#toggle-filters {
    background: white;
    border: 1px solid #ccc;
    cursor: pointer;
    font-size: 14px;
    color: #333;
    padding: 8px 12px;
    border-radius: 8px;
    display: flex;
    align-items: center;
    gap: 6px;
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
}

#toggle-filters:hover {
    background: #f8f9fa;
}

#open-new-window {
    background: white;
    border: 1px solid #ccc;
    cursor: pointer;
    font-size: 14px;
    color: #333;
    padding: 8px 10px;
    border-radius: 8px;
    display: flex;
    align-items: center;
    justify-content: center;
    min-width: 36px;
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
}

#open-new-window:hover {
    background: #f8f9fa;
}

.button-group {
    display: flex;
    gap: 8px;
}

#filter-container {
    position: absolute;
    top: 10px;
    right: 10px;
    z-index: 1001;
}

/* Network canvas styling */
#citation-network-container canvas {
    display: block;
}

/* Clean tooltip styling - completely override vis.js defaults */
.vis-tooltip {
    background: white !important;
    border: 1px solid #ccc !important;
    border-radius: 8px !important;
    padding: 8px !important;
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif !important;
    font-size: 14px !important;
    line-height: 1.6 !important;
    color: #333 !important;
    max-width: 350px !important;
    word-wrap: break-word !important;
    white-space: pre-wrap !important;
    overflow-wrap: break-word !important;
    box-shadow: none !important;
    -webkit-box-shadow: none !important;
    -moz-box-shadow: none !important;
}
</style>

<div id="citation-network-container">
    <div id="title-panel">
        <h1>Federal district court cases at which judges evaluated meta-analyses</h1>
        <h2>Citation network of cases at which judges either ruled on the admissability of meta-analyses as evidence or otherwise discussed them</h2>
    </div>
    
    <div id="filter-container">
        <div class="button-group">
            <button id="toggle-filters" onclick="toggleFilters()">Filter cases ☰</button>
            <button id="open-new-window" onclick="openInNewWindow()" title="Open in new window">⧉</button>
        </div>
        
        <div id="filter-panel">
            <div class="filter-group">
                <label>Document type:</label>
                <div class="checkbox-group" id="document-type-checkboxes">
                    <div class="checkbox-item"><input type="checkbox" id="doctype-0" value="Opinion" checked onchange="applyFilters()"><label for="doctype-0">Other document</label></div> <div class="checkbox-item"><input type="checkbox" id="doctype-1" value="Order" checked onchange="applyFilters()"><label for="doctype-1">Order</label></div>
                </div>
            </div>
            
            <div class="filter-group">
                <label>Circuit:</label>
                <div class="checkbox-group two-column" id="circuit-checkboxes">
                    <div class="checkbox-item"><input type="checkbox" id="circuit-0" value="1" checked onchange="applyFilters()"><label for="circuit-0">Circuit 1</label></div> <div class="checkbox-item"><input type="checkbox" id="circuit-1" value="2" checked onchange="applyFilters()"><label for="circuit-1">Circuit 2</label></div> <div class="checkbox-item"><input type="checkbox" id="circuit-2" value="3" checked onchange="applyFilters()"><label for="circuit-2">Circuit 3</label></div> <div class="checkbox-item"><input type="checkbox" id="circuit-3" value="4" checked onchange="applyFilters()"><label for="circuit-3">Circuit 4</label></div> <div class="checkbox-item"><input type="checkbox" id="circuit-4" value="5" checked onchange="applyFilters()"><label for="circuit-4">Circuit 5</label></div> <div class="checkbox-item"><input type="checkbox" id="circuit-5" value="6" checked onchange="applyFilters()"><label for="circuit-5">Circuit 6</label></div> <div class="checkbox-item"><input type="checkbox" id="circuit-6" value="7" checked onchange="applyFilters()"><label for="circuit-6">Circuit 7</label></div> <div class="checkbox-item"><input type="checkbox" id="circuit-7" value="8" checked onchange="applyFilters()"><label for="circuit-7">Circuit 8</label></div> <div class="checkbox-item"><input type="checkbox" id="circuit-8" value="9" checked onchange="applyFilters()"><label for="circuit-8">Circuit 9</label></div> <div class="checkbox-item"><input type="checkbox" id="circuit-9" value="10" checked onchange="applyFilters()"><label for="circuit-9">Circuit 10</label></div> <div class="checkbox-item"><input type="checkbox" id="circuit-10" value="11" checked onchange="applyFilters()"><label for="circuit-10">Circuit 11</label></div> <div class="checkbox-item"><input type="checkbox" id="circuit-11" value="MDL" checked onchange="applyFilters()"><label for="circuit-11">MDL (Multi-circuit)</label></div>
                </div>
            </div>
            
            <div class="filter-group">
                <label>Practice area:</label>
                <div class="checkbox-group" id="practice-area-checkboxes">
                    <div class="checkbox-item"><input type="checkbox" id="pa-0" value="Business/commercial" checked onchange="applyFilters()"><label for="pa-0">Business/commercial</label></div> <div class="checkbox-item"><input type="checkbox" id="pa-1" value="Constitutional/civil rights" checked onchange="applyFilters()"><label for="pa-1">Constitutional/civil rights</label></div> <div class="checkbox-item"><input type="checkbox" id="pa-2" value="Criminal" checked onchange="applyFilters()"><label for="pa-2">Criminal</label></div> <div class="checkbox-item"><input type="checkbox" id="pa-3" value="Other civil suit" checked onchange="applyFilters()"><label for="pa-3">Other civil suit</label></div> <div class="checkbox-item"><input type="checkbox" id="pa-4" value="Pharma tort" checked onchange="applyFilters()"><label for="pa-4">Pharma tort</label></div> <div class="checkbox-item"><input type="checkbox" id="pa-5" value="Toxic tort" checked onchange="applyFilters()"><label for="pa-5">Toxic tort</label></div>
                </div>
            </div>
            
            <div class="filter-group">
                <label>Introducing party:</label>
                <div class="checkbox-group" id="introducing-party-checkboxes">
                    <div class="checkbox-item"><input type="checkbox" id="party-0" value="Defense" checked onchange="applyFilters()"><label for="party-0">Defense</label></div> <div class="checkbox-item"><input type="checkbox" id="party-1" value="Plaintiff" checked onchange="applyFilters()"><label for="party-1">Plaintiff</label></div> <div class="checkbox-item"><input type="checkbox" id="party-2" value="Both" checked onchange="applyFilters()"><label for="party-2">Both</label></div>
                </div>
            </div>
             
            <div class="filter-group">
                <label>Outcome:</label>
                <div class="checkbox-group" id="admission-checkboxes">
                    <div class="checkbox-item"><input type="checkbox" id="dot" value="dot" checked onchange="applyFilters()"><label for="dot">Admitted/accepted</label></div>
                    <div class="checkbox-item"><input type="checkbox" id="square" value="square" checked onchange="applyFilters()"><label for="square">Excluded/rejected</label></div>
                    <div class="checkbox-item"><input type="checkbox" id="triangle" value="triangle" checked onchange="applyFilters()"><label for="triangle">Mixed</label></div>
                </div>
            </div>
            
            <div class="filter-group">
                <label>Expert discipline:</label>
                <div class="checkbox-group" id="expert-discipline-checkboxes">
                    <div class="checkbox-item"><input type="checkbox" id="discipline-0" value="Epidemiology" checked onchange="applyFilters()"><label for="discipline-0">Epidemiology</label></div> <div class="checkbox-item"><input type="checkbox" id="discipline-1" value="Interdisciplinary team" checked onchange="applyFilters()"><label for="discipline-1">Interdisciplinary team</label></div> <div class="checkbox-item"><input type="checkbox" id="discipline-2" value="Life sciences" checked onchange="applyFilters()"><label for="discipline-2">Life sciences</label></div> <div class="checkbox-item"><input type="checkbox" id="discipline-3" value="Mathematics/statistics" checked onchange="applyFilters()"><label for="discipline-3">Mathematics/statistics</label></div> <div class="checkbox-item"><input type="checkbox" id="discipline-4" value="Medicine" checked onchange="applyFilters()"><label for="discipline-4">Medicine</label></div> <div class="checkbox-item"><input type="checkbox" id="discipline-5" value="Psychology" checked onchange="applyFilters()"><label for="discipline-5">Psychology</label></div> <div class="checkbox-item"><input type="checkbox" id="discipline-6" value="Social sciences" checked onchange="applyFilters()"><label for="discipline-6">Social sciences</label></div>
                </div>
            </div>
            
            <div class="filter-group">
                <label>Additional options:</label>
                <div class="checkbox-group" id="additional-options-checkboxes">
                    <div class="checkbox-item"><input type="checkbox" id="show-isolated" value="show-isolated" onchange="applyFilters()"><label for="show-isolated">Show cases with no citations</label></div>
                </div>
            </div>
        </div>
    </div>

    <div id="legend-panel">
        <div style="margin-bottom: 8px;">
            <div style="margin-bottom: 2px; font-size: 11px;">● Meta-analysis treated positively</div>
            <div style="margin-bottom: 2px; font-size: 11px;">■ Meta-analysis treated negatively</div>
            <div style="margin-bottom: 4px; font-size: 11px;">▲ Mixed results</div>
        </div>
        
        <div style="border-top: 1px solid #ccc; margin: 8px 0; padding-top: 8px;">
            <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 2px; font-size: 11px;">
                <div><span style="color: #e8d5a3; font-weight: bold;">●</span> Circuit 1</div>
                <div><span style="color: #d4a574; font-weight: bold;">●</span> Circuit 2</div>
                <div><span style="color: #b8876b; font-weight: bold;">●</span> Circuit 3</div>
                <div><span style="color: #a67c7c; font-weight: bold;">●</span> Circuit 4</div>
                <div><span style="color: #9c7ba6; font-weight: bold;">●</span> Circuit 5</div>
                <div><span style="color: #7a82a8; font-weight: bold;">●</span> Circuit 6</div>
                <div><span style="color: #6b8ba3; font-weight: bold;">●</span> Circuit 7</div>
                <div><span style="color: #5d8e95; font-weight: bold;">●</span> Circuit 8</div>
                <div><span style="color: #5a9185; font-weight: bold;">●</span> Circuit 9</div>
                <div><span style="color: #6b9174; font-weight: bold;">●</span> Circuit 10</div>
                <div><span style="color: #829565; font-weight: bold;">●</span> Circuit 11</div>
                <div style="grid-column: 1 / -1; margin-top: 2px;"><span style="color: #4a4a4a; font-weight: bold;">●</span> Multi-circuit (MDL)</div>
            </div>
        </div>
    </div>
</div>

<script>
let allNodesData = [];
let allEdgesData = [];
let filteredNodes = [];
let filteredEdges = [];

// Store original data when network loads and immediately hide isolated nodes
setTimeout(function() {
    allNodesData = nodes.get();
    allEdgesData = edges.get();
    
    // Immediately hide isolated nodes on load
    const nonIsolatedNodes = allNodesData.filter(node => !node.is_isolated);
    nodes.clear();
    nodes.add(nonIsolatedNodes);
    
    // Apply full filters
    applyFilters();
}, 100);

function toggleFilters() {
    const panel = document.getElementById('filter-panel');
    panel.classList.toggle('show');
}

function openInNewWindow() {
    // Get the current page URL
    const currentUrl = window.location.href;
    
    // Open in a new window with optimal size for the network
    window.open(currentUrl, '_blank', 'width=1200,height=800,scrollbars=yes,resizable=yes');
}

function applyFilters() {
    // Get filter values from checkboxes
    const selectedDocTypes = Array.from(document.querySelectorAll('#document-type-checkboxes input[type="checkbox"]:checked'))
        .map(cb => cb.value);
    const selectedCircuits = Array.from(document.querySelectorAll('#circuit-checkboxes input[type="checkbox"]:checked'))
        .map(cb => cb.value);
    const selectedAreas = Array.from(document.querySelectorAll('#practice-area-checkboxes input[type="checkbox"]:checked'))
        .map(cb => cb.value);
    const selectedParties = Array.from(document.querySelectorAll('#introducing-party-checkboxes input[type="checkbox"]:checked'))
        .map(cb => cb.value);
    const selectedShapes = Array.from(document.querySelectorAll('#admission-checkboxes input[type="checkbox"]:checked'))
        .map(cb => cb.value);
    const selectedDisciplines = Array.from(document.querySelectorAll('#expert-discipline-checkboxes input[type="checkbox"]:checked'))
        .map(cb => cb.value);
    const showIsolated = document.querySelector('#show-isolated').checked;
    
    // Filter nodes
    filteredNodes = allNodesData.filter(node => {
        // Isolated cases filter - if not showing isolated and node is isolated, hide it
        if (!showIsolated && node.is_isolated) {
            return false;
        }
        
        // Document type filter - if no types selected, show nothing
        // "Both" nodes show if either Order or Other document is selected
        if (selectedDocTypes.length === 0) {
            return false;
        }
        const nodeDocType = node.document_type;
        if (nodeDocType === "Both") {
            // Show if either Order or Opinion (Other document) is selected
            if (!selectedDocTypes.includes("Order") && !selectedDocTypes.includes("Opinion")) {
                return false;
            }
        } else if (!selectedDocTypes.includes(nodeDocType)) {
            return false;
        }
        
        // Circuit filter - if no circuits selected, show nothing
        if (selectedCircuits.length === 0) {
            return false;
        }
        // Handle circuit filtering: check both numeric circuits and "MDL" for multi-circuit
        const nodeCircuitStr = node.circuit.toString();
        if (!selectedCircuits.includes(nodeCircuitStr)) {
            return false;
        }
        
        // Practice area filter - if no areas selected, show nothing
        if (selectedAreas.length === 0) {
            return false;
        }
        if (!selectedAreas.includes(node.practice_area)) {
            return false;
        }
        
        // Introducing party filter - if no parties selected, show nothing
        if (selectedParties.length === 0) {
            return false;
        }
        if (!selectedParties.includes(node.introducing_party)) {
            return false;
        }
        
        // Shape filter - if no shapes selected, show nothing
        if (selectedShapes.length === 0) {
            return false;
        }
        if (!selectedShapes.includes(node.shape)) {
            return false;
        }
        
        // Expert discipline filter - if no disciplines selected, show nothing
        if (selectedDisciplines.length === 0) {
            return false;
        }
        // Check if any of the node's disciplines match the selected ones
        const nodeDisciplines = node.expert_disciplines.split(', ');
        const hasMatchingDiscipline = nodeDisciplines.some(discipline => 
            selectedDisciplines.includes(discipline.trim()) || discipline.trim() === 'N/A'
        );
        if (!hasMatchingDiscipline) {
            return false;
        }
        
        return true;
    });
    
    // Filter edges (only keep edges between visible nodes)
    const visibleNodeIds = new Set(filteredNodes.map(n => n.id));
    filteredEdges = allEdgesData.filter(edge => 
        visibleNodeIds.has(edge.from) && visibleNodeIds.has(edge.to)
    );
    
    // Update network
    nodes.clear();
    edges.clear();
    nodes.add(filteredNodes);
    edges.add(filteredEdges);
}
</script> <div id="mynetwork" class="card-body"></div>
        </div>

        
            <div id="loadingBar">
              <div class="outerBorder">
                <div id="text">0%</div>
                <div id="border">
                  <div id="bar"></div>
                </div>
              </div>
            </div>
        
        

        <script type="text/javascript">

              // initialize global variables.
              var edges;
              var nodes;
              var allNodes;
              var allEdges;
              var nodeColors;
              var originalNodes;
              var network;
              var container;
              var options, data;
              var filter = {
                  item : '',
                  property : '',
                  value : []
              };

              

              

              // This method is responsible for drawing the graph, returns the drawn network
              function drawGraph() {
                  var container = document.getElementById('mynetwork');

                  

                  // parsing and collecting nodes and edges from the python
                  nodes = new vis.DataSet([{"admitted": false, "circuit": 2, "citation_count": 0, "color": "#d4a574", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Aghaeepour v. N. Leasing Sys.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Aghaeepour v. N. Leasing Sys.", "practice_area": "Business/commercial", "shape": "square", "size": 10, "title": "Aghaeepour v. N. Leasing Sys.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 14-CV-5449-NSR\nYear: 2024\nPractice area: Business/commercial\nExpert discipline(s): Social sciences", "year": 2024}, {"admitted": false, "circuit": 6, "citation_count": 2, "color": "#7a82a8", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Bailey v. Nyloncraft, Inc.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Bailey v. Nyloncraft, Inc.", "practice_area": "Other civil suit", "shape": "square", "size": 16, "title": "Bailey v. Nyloncraft, Inc.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 11-CV-14199-GCS\nYear: 2012\nPractice area: Other civil suit\nExpert discipline(s): Social sciences", "year": 2012}, {"admitted": false, "circuit": 6, "citation_count": 2, "color": "#7a82a8", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Baker v. Chevron USA, Inc.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Baker v. Chevron USA, Inc.", "practice_area": "Toxic tort", "shape": "square", "size": 16, "title": "Baker v. Chevron USA, Inc.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 1:05-CV-227-SSB\nYear: 2010\nPractice area: Toxic tort\nExpert discipline(s): Medicine", "year": 2010}, {"admitted": true, "circuit": 9, "citation_count": 0, "color": "#5a9185", "document_type": "Opinion", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Barrera v. Pharmavite", "introducing_party": "Defense", "is_isolated": false, "label": "Barrera v. Pharmavite", "practice_area": "Business/commercial", "shape": "dot", "size": 10, "title": "Barrera v. Pharmavite\n[Other document]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 11-CV-4153-CAS\nYear: 2016\nPractice area: Business/commercial\nExpert discipline(s): Medicine", "year": 2016}, {"admitted": true, "circuit": 9, "citation_count": 0, "color": "#5a9185", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Behar et al v. Northrup Grumman Corporation", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Behar et al v. Northrup Grumman Corporation", "practice_area": "Other civil suit", "shape": "dot", "size": 10, "title": "Behar et al v. Northrup Grumman Corporation\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 2:21-CV-03946-HDV\nYear: 2024\nPractice area: Other civil suit\nExpert discipline(s): Social sciences", "year": 2024}, {"admitted": true, "circuit": 8, "citation_count": 1, "color": "#5d8e95", "document_type": "Order", "expert_disciplines": "Epidemiology", "font": {"color": "black"}, "id": "Berg v. Johnson \u0026 Johnson Consumer Cos.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Berg v. Johnson \u0026 Johnson Consumer Cos.", "practice_area": "Toxic tort", "shape": "dot", "size": 13, "title": "Berg v. Johnson \u0026 Johnson Consumer Cos.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 4:09-CV-4179-KES\nYear: 2013\nPractice area: Toxic tort\nExpert discipline(s): Epidemiology", "year": 2013}, {"admitted": true, "circuit": 6, "citation_count": 1, "color": "#7a82a8", "document_type": "Opinion", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "Bristol v. Slatery", "introducing_party": "Both", "is_isolated": false, "label": "Bristol v. Slatery", "practice_area": "Constitutional/civil rights", "shape": "triangle", "size": 13, "title": "Bristol v. Slatery\n[Other document]\nMeta-analysis introduced by plaintiff(s) (admitted) and defendant(s) (excluded)\nCase number: 15-CV-6267-BAF\nYear: 2020\nPractice area: Constitutional/civil rights\nExpert discipline(s): Psychology", "year": 2020}, {"admitted": false, "circuit": 2, "citation_count": 2, "color": "#d4a574", "document_type": "Order", "expert_disciplines": "Life sciences", "font": {"color": "black"}, "id": "Daniels-Feasel v. Forest Pharms., Inc.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Daniels-Feasel v. Forest Pharms., Inc.", "practice_area": "Toxic tort", "shape": "square", "size": 16, "title": "Daniels-Feasel v. Forest Pharms., Inc.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 17-CV-4188-LTS-JLC\nYear: 2021\nPractice area: Toxic tort\nExpert discipline(s): Life sciences", "year": 2021}, {"admitted": false, "circuit": 9, "citation_count": 1, "color": "#5a9185", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Davis v. McKesson Corp.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Davis v. McKesson Corp.", "practice_area": "Pharma tort", "shape": "square", "size": 13, "title": "Davis v. McKesson Corp.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 18-CV-1157-PHX-DGC;18-CV-1159-PHX-DGC;18-CV-1778-PHX-DGC\nYear: 2019\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 2019}, {"admitted": true, "circuit": 7, "citation_count": 0, "color": "#6b8ba3", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Dolin v. SmithKline Beecham Corp.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Dolin v. SmithKline Beecham Corp.", "practice_area": "Pharma tort", "shape": "dot", "size": 10, "title": "Dolin v. SmithKline Beecham Corp.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 12-CV-6403-JBZ\nYear: 2015\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 2015}, {"admitted": true, "circuit": 2, "citation_count": 0, "color": "#d4a574", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Drake v. Allergan", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Drake v. Allergan", "practice_area": "Pharma tort", "shape": "dot", "size": 10, "title": "Drake v. Allergan\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 2:13-CV-234-WKS\nYear: 2014\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 2014}, {"admitted": false, "circuit": 7, "citation_count": 2, "color": "#6b8ba3", "document_type": "Opinion", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "Entm\u0027t Software Ass\u0027n v. Blagojevich", "introducing_party": "Defense", "is_isolated": false, "label": "Entm\u0027t Software Ass\u0027n v. Blagojevich", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 16, "title": "Entm\u0027t Software Ass\u0027n v. Blagojevich\n[Other document]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: 1:05-CV-04265-MFK\nYear: 2005\nPractice area: Constitutional/civil rights\nExpert discipline(s): Psychology", "year": 2005}, {"admitted": false, "circuit": 8, "citation_count": 1, "color": "#5d8e95", "document_type": "Opinion", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "Entm\u0027t Software Ass\u0027n v. Hatch", "introducing_party": "Defense", "is_isolated": false, "label": "Entm\u0027t Software Ass\u0027n v. Hatch", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 13, "title": "Entm\u0027t Software Ass\u0027n v. Hatch\n[Other document]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: 06-CV-2268\nYear: 2006\nPractice area: Constitutional/civil rights\nExpert discipline(s): Psychology", "year": 2006}, {"admitted": false, "circuit": 7, "citation_count": 0, "color": "#6b8ba3", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Est. of Warner v. Wellpath", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Est. of Warner v. Wellpath", "practice_area": "Other civil suit", "shape": "square", "size": 10, "title": "Est. of Warner v. Wellpath\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 1:19-CV-00774-RLY-MJD\nYear: 2021\nPractice area: Other civil suit\nExpert discipline(s): Social sciences", "year": 2021}, {"admitted": false, "circuit": 8, "citation_count": 2, "color": "#5d8e95", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Families Advocate, LLC v. Sanford Clinic N.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Families Advocate, LLC v. Sanford Clinic N.", "practice_area": "Other civil suit", "shape": "square", "size": 16, "title": "Families Advocate, LLC v. Sanford Clinic N.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 3:16-CV-114-ARS\nYear: 2019\nPractice area: Other civil suit\nExpert discipline(s): Social sciences", "year": 2019}, {"admitted": false, "circuit": 7, "citation_count": 2, "color": "#6b8ba3", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Glisson v. Corr. Med. Servs.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Glisson v. Corr. Med. Servs.", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 16, "title": "Glisson v. Corr. Med. Servs.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 1:12-CV-01418-SEB-MJD\nYear: 2018\nPractice area: Constitutional/civil rights\nExpert discipline(s): Social sciences", "year": 2018}, {"admitted": false, "circuit": 4, "citation_count": 0, "color": "#a67c7c", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Goodrich v. John Crane Inc.", "introducing_party": "Defense", "is_isolated": false, "label": "Goodrich v. John Crane Inc.", "practice_area": "Toxic tort", "shape": "square", "size": 10, "title": "Goodrich v. John Crane Inc.\n[Order]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: 4:17-CV-9-RJK\nYear: 2018\nPractice area: Toxic tort\nExpert discipline(s): Medicine", "year": 2018}, {"admitted": false, "circuit": 2, "citation_count": 0, "color": "#d4a574", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Hasemann v. Gerber Prods. Co.", "introducing_party": "Defense", "is_isolated": false, "label": "Hasemann v. Gerber Prods. Co.", "practice_area": "Business/commercial", "shape": "square", "size": 10, "title": "Hasemann v. Gerber Prods. Co.\n[Order]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: 1:15-CV-02995-EK-JAM\nYear: 2024\nPractice area: Business/commercial\nExpert discipline(s): Medicine", "year": 2024}, {"admitted": true, "circuit": 6, "citation_count": 0, "color": "#7a82a8", "document_type": "Order", "expert_disciplines": "Interdisciplinary team", "font": {"color": "black"}, "id": "In re Flint Water Cases", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Flint Water Cases", "practice_area": "Toxic tort", "shape": "dot", "size": 10, "title": "In re Flint Water Cases\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 17-CV-10164-JEL\nYear: 2021\nPractice area: Toxic tort\nExpert discipline(s): Interdisciplinary team", "year": 2021}, {"admitted": true, "circuit": 9, "citation_count": 3, "color": "#5a9185", "document_type": "Order", "expert_disciplines": "Life sciences", "font": {"color": "black"}, "id": "Johns v. Bayer Corp.", "introducing_party": "Defense", "is_isolated": false, "label": "Johns v. Bayer Corp.", "practice_area": "Business/commercial", "shape": "dot", "size": 19, "title": "Johns v. Bayer Corp.\n[Order]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 09-CV-1935-AJB\nYear: 2013\nPractice area: Business/commercial\nExpert discipline(s): Life sciences", "year": 2013}, {"admitted": false, "circuit": 5, "citation_count": 9, "color": "#9c7ba6", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Knight v. Kirby Inland Marine, Inc.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Knight v. Kirby Inland Marine, Inc.", "practice_area": "Toxic tort", "shape": "square", "size": 37, "title": "Knight v. Kirby Inland Marine, Inc.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 4:01-CV-223-WAP\nYear: 2005\nPractice area: Toxic tort\nExpert discipline(s): Medicine", "year": 2005}, {"admitted": true, "circuit": 9, "citation_count": 0, "color": "#5a9185", "document_type": "Order", "expert_disciplines": "Interdisciplinary team", "font": {"color": "black"}, "id": "Korolshteyn v. Costco Wholesale Corp.", "introducing_party": "Defense", "is_isolated": false, "label": "Korolshteyn v. Costco Wholesale Corp.", "practice_area": "Business/commercial", "shape": "dot", "size": 10, "title": "Korolshteyn v. Costco Wholesale Corp.\n[Order]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 3:15-CV-709-CAB-RBB\nYear: 2017\nPractice area: Business/commercial\nExpert discipline(s): Interdisciplinary team", "year": 2017}, {"admitted": false, "circuit": 5, "citation_count": 0, "color": "#9c7ba6", "document_type": "Order", "expert_disciplines": "Mathematics/statistics", "font": {"color": "black"}, "id": "LeBlanc v. Chevron USA Inc.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "LeBlanc v. Chevron USA Inc.", "practice_area": "Toxic tort", "shape": "square", "size": 10, "title": "LeBlanc v. Chevron USA Inc.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 2:05-CV-05485-AJM\nYear: 2009\nPractice area: Toxic tort\nExpert discipline(s): Mathematics/statistics", "year": 2009}, {"admitted": true, "circuit": 8, "citation_count": 0, "color": "#5d8e95", "document_type": "Order", "expert_disciplines": "Interdisciplinary team", "font": {"color": "black"}, "id": "Lemberger v. Union Pac. R.R. Co.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Lemberger v. Union Pac. R.R. Co.", "practice_area": "Toxic tort", "shape": "dot", "size": 10, "title": "Lemberger v. Union Pac. R.R. Co.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 8:18-CV-64-JFB\nYear: 2020\nPractice area: Toxic tort\nExpert discipline(s): Interdisciplinary team", "year": 2020}, {"admitted": true, "circuit": 9, "citation_count": 0, "color": "#5a9185", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Lewert v. Boiron", "introducing_party": "Defense", "is_isolated": false, "label": "Lewert v. Boiron", "practice_area": "Business/commercial", "shape": "dot", "size": 10, "title": "Lewert v. Boiron\n[Order]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 11-CV-10803-AB\nYear: 2016\nPractice area: Business/commercial\nExpert discipline(s): Medicine", "year": 2016}, {"admitted": false, "circuit": 3, "citation_count": 8, "color": "#b8876b", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Magistrini v. One Hour Martinizing Dry Cleaning", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Magistrini v. One Hour Martinizing Dry Cleaning", "practice_area": "Toxic tort", "shape": "square", "size": 34, "title": "Magistrini v. One Hour Martinizing Dry Cleaning\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 96-CV-4991-FSH\nYear: 2002\nPractice area: Toxic tort\nExpert discipline(s): Medicine", "year": 2002}, {"admitted": false, "circuit": 2, "citation_count": 0, "color": "#d4a574", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Mallozzi v. Ecosmart Techs., Inc.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Mallozzi v. Ecosmart Techs., Inc.", "practice_area": "Other civil suit", "shape": "square", "size": 10, "title": "Mallozzi v. Ecosmart Techs., Inc.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 11-CV-2884-SJF\nYear: 2013\nPractice area: Other civil suit\nExpert discipline(s): Medicine", "year": 2013}, {"admitted": false, "circuit": 8, "citation_count": 1, "color": "#5d8e95", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "McLaughlin v. BNSF Ry. Co.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "McLaughlin v. BNSF Ry. Co.", "practice_area": "Toxic tort", "shape": "square", "size": 13, "title": "McLaughlin v. BNSF Ry. Co.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 4:18-CV-3047-JMG\nYear: 2020\nPractice area: Toxic tort\nExpert discipline(s): Medicine", "year": 2020}, {"admitted": true, "circuit": 11, "citation_count": 0, "color": "#829565", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "McWilliams v. Novartis AG", "introducing_party": "Plaintiff", "is_isolated": false, "label": "McWilliams v. Novartis AG", "practice_area": "Pharma tort", "shape": "dot", "size": 10, "title": "McWilliams v. Novartis AG\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 2:17-CV-14302-RLR-SMS\nYear: 2018\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 2018}, {"admitted": false, "circuit": 10, "citation_count": 2, "color": "#6b9174", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Miller v. Pfizer", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Miller v. Pfizer", "practice_area": "Pharma tort", "shape": "square", "size": 16, "title": "Miller v. Pfizer\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 99-CV-2326-KHV\nYear: 2002\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 2002}, {"admitted": false, "circuit": 8, "citation_count": 1, "color": "#5d8e95", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Moe v. Grinnell College", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Moe v. Grinnell College", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 13, "title": "Moe v. Grinnell College\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 4:20-CV-00058-RGE-SBJ\nYear: 2021\nPractice area: Constitutional/civil rights\nExpert discipline(s): Social sciences", "year": 2021}, {"admitted": true, "circuit": 9, "citation_count": 3, "color": "#5a9185", "document_type": "Order", "expert_disciplines": "Life sciences", "font": {"color": "black"}, "id": "Mullins v. Premier Nutrition Corp.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Mullins v. Premier Nutrition Corp.", "practice_area": "Business/commercial", "shape": "dot", "size": 19, "title": "Mullins v. Premier Nutrition Corp.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 13-CV-01271-RS\nYear: 2016\nPractice area: Business/commercial\nExpert discipline(s): Life sciences", "year": 2016}, {"admitted": true, "circuit": 7, "citation_count": 0, "color": "#6b8ba3", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Newman v. McNeil Consumer Healthcare", "introducing_party": "Defense", "is_isolated": false, "label": "Newman v. McNeil Consumer Healthcare", "practice_area": "Pharma tort", "shape": "dot", "size": 10, "title": "Newman v. McNeil Consumer Healthcare\n[Order]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 10-CV-1541-MV\nYear: 2013\nPractice area: Pharma tort\nExpert discipline(s): Social sciences", "year": 2013}, {"admitted": true, "circuit": 2, "citation_count": 0, "color": "#d4a574", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Oliver v. Am. Express Co.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Oliver v. Am. Express Co.", "practice_area": "Business/commercial", "shape": "dot", "size": 10, "title": "Oliver v. Am. Express Co.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 19-CV-566-NGG\nYear: 2024\nPractice area: Business/commercial\nExpert discipline(s): Social sciences", "year": 2024}, {"admitted": true, "circuit": 10, "citation_count": 0, "color": "#6b9174", "document_type": "Order", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "Palmer v. Asarco Inc.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Palmer v. Asarco Inc.", "practice_area": "Toxic tort", "shape": "dot", "size": 10, "title": "Palmer v. Asarco Inc.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 03-CV-0498-CVE-PJC\nYear: 2007\nPractice area: Toxic tort\nExpert discipline(s): Psychology", "year": 2007}, {"admitted": true, "circuit": 3, "citation_count": 2, "color": "#b8876b", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Patrick v. FirstEnergy Generation Corp.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Patrick v. FirstEnergy Generation Corp.", "practice_area": "Toxic tort", "shape": "dot", "size": 16, "title": "Patrick v. FirstEnergy Generation Corp.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 2:08-CV-01025-JFC\nYear: 2014\nPractice area: Toxic tort\nExpert discipline(s): Social sciences", "year": 2014}, {"admitted": false, "circuit": 2, "citation_count": 1, "color": "#d4a574", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Rizzo v. Applied Materials, Inc.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Rizzo v. Applied Materials, Inc.", "practice_area": "Toxic tort", "shape": "square", "size": 13, "title": "Rizzo v. Applied Materials, Inc.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 6:15-CV-557-MAD\nYear: 2017\nPractice area: Toxic tort\nExpert discipline(s): Medicine", "year": 2017}, {"admitted": false, "circuit": 2, "citation_count": 1, "color": "#d4a574", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Santiago v. Fischer", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Santiago v. Fischer", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 13, "title": "Santiago v. Fischer\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 09-CV-1383-MKB\nYear: 2020\nPractice area: Constitutional/civil rights\nExpert discipline(s): Social sciences", "year": 2020}, {"admitted": true, "circuit": 9, "citation_count": 0, "color": "#5a9185", "document_type": "Order", "expert_disciplines": "Mathematics/statistics", "font": {"color": "black"}, "id": "Sentius Int\u0027l, LLC v. Microsoft Corp.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Sentius Int\u0027l, LLC v. Microsoft Corp.", "practice_area": "Business/commercial", "shape": "dot", "size": 10, "title": "Sentius Int\u0027l, LLC v. Microsoft Corp.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 5:13-CV-00825-PSG\nYear: 2015\nPractice area: Business/commercial\nExpert discipline(s): Mathematics/statistics", "year": 2015}, {"admitted": true, "circuit": 9, "citation_count": 1, "color": "#5a9185", "document_type": "Order", "expert_disciplines": "Life sciences, Medicine", "font": {"color": "black"}, "id": "Sonner v. Schwabe N. Am., Inc.", "introducing_party": "Both", "is_isolated": false, "label": "Sonner v. Schwabe N. Am., Inc.", "practice_area": "Business/commercial", "shape": "dot", "size": 13, "title": "Sonner v. Schwabe N. Am., Inc.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted) and defendant(s) (admitted)\nCase number: 15-CV-1358-VAP\nYear: 2017\nPractice area: Business/commercial\nExpert discipline(s): Life sciences, Medicine", "year": 2017}, {"admitted": false, "circuit": 9, "citation_count": 0, "color": "#5a9185", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Starling v. Banner Health", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Starling v. Banner Health", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 10, "title": "Starling v. Banner Health\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 16-CV-00708-PHX-NVW\nYear: 2018\nPractice area: Constitutional/civil rights\nExpert discipline(s): Social sciences", "year": 2018}, {"admitted": true, "circuit": 9, "citation_count": 0, "color": "#5a9185", "document_type": "Order", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "Stathakos v. Columbia Sportswear Co.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Stathakos v. Columbia Sportswear Co.", "practice_area": "Business/commercial", "shape": "dot", "size": 10, "title": "Stathakos v. Columbia Sportswear Co.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 15-CV-04543-YGR\nYear: 2017\nPractice area: Business/commercial\nExpert discipline(s): Psychology", "year": 2017}, {"admitted": false, "circuit": 7, "citation_count": 5, "color": "#6b8ba3", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Stokes v. John Deere Seeding Group", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Stokes v. John Deere Seeding Group", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 25, "title": "Stokes v. John Deere Seeding Group\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 4:12-CV-04054-SLD-JAG\nYear: 2014\nPractice area: Constitutional/civil rights\nExpert discipline(s): Social sciences", "year": 2014}, {"admitted": true, "circuit": 7, "citation_count": 3, "color": "#6b8ba3", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Tucker v. SmithKline Beecham Corp.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Tucker v. SmithKline Beecham Corp.", "practice_area": "Pharma tort", "shape": "dot", "size": 19, "title": "Tucker v. SmithKline Beecham Corp.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 1:04-CV-1748-DFH-DML\nYear: 2010\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 2010}, {"admitted": true, "circuit": 3, "citation_count": 1, "color": "#b8876b", "document_type": "Order", "expert_disciplines": "Life sciences", "font": {"color": "black"}, "id": "United States v. Bayer Corp.", "introducing_party": "Defense", "is_isolated": false, "label": "United States v. Bayer Corp.", "practice_area": "Business/commercial", "shape": "dot", "size": 13, "title": "United States v. Bayer Corp.\n[Order]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 2:07-CV-00001-JLL-JAD\nYear: 2015\nPractice area: Business/commercial\nExpert discipline(s): Life sciences", "year": 2015}, {"admitted": true, "circuit": 5, "citation_count": 0, "color": "#9c7ba6", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "United States v. Jordan", "introducing_party": "Defense", "is_isolated": false, "label": "United States v. Jordan", "practice_area": "Criminal", "shape": "dot", "size": 10, "title": "United States v. Jordan\n[Order]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 3:18-CR-67-CWR-LGI-1\nYear: 2023\nPractice area: Criminal\nExpert discipline(s): Social sciences", "year": 2023}, {"admitted": false, "circuit": 11, "citation_count": 2, "color": "#829565", "document_type": "Order", "expert_disciplines": "Life sciences", "font": {"color": "black"}, "id": "Vandestreek v. Lockheed Martin Corp.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Vandestreek v. Lockheed Martin Corp.", "practice_area": "Toxic tort", "shape": "square", "size": 16, "title": "Vandestreek v. Lockheed Martin Corp.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 6:21-CV-1570-RBD-DCI\nYear: 2023\nPractice area: Toxic tort\nExpert discipline(s): Life sciences", "year": 2023}, {"admitted": false, "circuit": 9, "citation_count": 1, "color": "#5a9185", "document_type": "Opinion", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "Video Software Dealers Association v. Schwarzenegger", "introducing_party": "Defense", "is_isolated": false, "label": "Video Software Dealers Association v. Schwarzenegg...", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 13, "title": "Video Software Dealers Association v. Schwarzenegger\n[Other document]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: 05-CV-04188-RMW\nYear: 2007\nPractice area: Constitutional/civil rights\nExpert discipline(s): Psychology", "year": 2007}, {"admitted": true, "circuit": 5, "citation_count": 1, "color": "#9c7ba6", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Wagoner v. Exxon Mobil Corp.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Wagoner v. Exxon Mobil Corp.", "practice_area": "Toxic tort", "shape": "dot", "size": 13, "title": "Wagoner v. Exxon Mobil Corp.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 09-CV-7257-EEF\nYear: 2011\nPractice area: Toxic tort\nExpert discipline(s): Medicine", "year": 2011}, {"admitted": true, "circuit": 4, "citation_count": 0, "color": "#a67c7c", "document_type": "Order", "expert_disciplines": "Interdisciplinary team, Epidemiology", "font": {"color": "black"}, "id": "Walls v. Ford Motor Co.", "introducing_party": "Defense", "is_isolated": false, "label": "Walls v. Ford Motor Co.", "practice_area": "Toxic tort", "shape": "triangle", "size": 10, "title": "Walls v. Ford Motor Co.\n[Order]\nMeta-analysis introduced by defendant(s) (mixed)\nCase number: 1:20-CV-98-LCB\nYear: 2022\nPractice area: Toxic tort\nExpert discipline(s): Interdisciplinary team, Epidemiology", "year": 2022}, {"admitted": true, "circuit": 7, "citation_count": 0, "color": "#6b8ba3", "document_type": "Order", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "Whole Woman\u0027s Health Alliance v. Rokita", "introducing_party": "Defense", "is_isolated": false, "label": "Whole Woman\u0027s Health Alliance v. Rokita", "practice_area": "Constitutional/civil rights", "shape": "dot", "size": 10, "title": "Whole Woman\u0027s Health Alliance v. Rokita\n[Order]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 1:18-CV-01904-SEB-MJD\nYear: 2021\nPractice area: Constitutional/civil rights\nExpert discipline(s): Psychology", "year": 2021}, {"admitted": false, "circuit": 8, "citation_count": 0, "color": "#5d8e95", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Zarling v. Abbott Labs", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Zarling v. Abbott Labs", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 10, "title": "Zarling v. Abbott Labs\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 21-CV-23-MJD\nYear: 2023\nPractice area: Constitutional/civil rights\nExpert discipline(s): Social sciences", "year": 2023}, {"admitted": false, "circuit": 4, "citation_count": 1, "color": "#a67c7c", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Ziegler v. Polaris Indus.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Ziegler v. Polaris Indus.", "practice_area": "Other civil suit", "shape": "square", "size": 13, "title": "Ziegler v. Polaris Indus.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 1:23-CV-00112-MR-WCM\nYear: 2024\nPractice area: Other civil suit\nExpert discipline(s): Social sciences", "year": 2024}, {"admitted": true, "circuit": "MDL", "citation_count": 6, "color": "#4a4a4a", "document_type": "Order", "expert_disciplines": "Epidemiology", "font": {"color": "black"}, "id": "MDL-1760", "introducing_party": "Plaintiff", "is_isolated": false, "label": "MDL-1760: Bartoli v. Novartis Pharms. Co... (+9 more)", "practice_area": "Pharma tort", "shape": "triangle", "size": 28, "title": "MDL 1760\nCases: Bartoli v. Novartis Pharms. Corp., Chiles v. Novartis Pharms. Corp., Deutsch v. Novartis Pharms. Corp....\n[Order]\nMeta-analysis introduced by plaintiff(s) (mixed)\nCase number: 3:13-CV-0724-MEM, 3:06-CV-96-J-25-JBT, 09-CV-4677-ADS...\nYear: 2011-2014\nPractice area: Pharma tort\nExpert discipline(s): Epidemiology", "year": 2011}, {"admitted": true, "circuit": 9, "citation_count": 7, "color": "#5a9185", "document_type": "Order", "expert_disciplines": "Epidemiology", "font": {"color": "black"}, "id": "Cagle v. Cooper Cos.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Cagle v. Cooper Cos.", "practice_area": "Pharma tort", "shape": "dot", "size": 31, "title": "Cagle v. Cooper Cos.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 96-CV-6545-AHM\nYear: 2004\nPractice area: Pharma tort\nExpert discipline(s): Epidemiology", "year": 2004}, {"admitted": false, "circuit": 11, "citation_count": 0, "color": "#829565", "document_type": "Order", "expert_disciplines": "Epidemiology", "font": {"color": "black"}, "id": "Culliver v. BP Expl. \u0026 Prod., Inc.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Culliver v. BP Expl. \u0026 Prod., Inc.", "practice_area": "Toxic tort", "shape": "square", "size": 10, "title": "Culliver v. BP Expl. \u0026 Prod., Inc.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 3:21-CV-4942-MCR-HTC\nYear: 2024\nPractice area: Toxic tort\nExpert discipline(s): Epidemiology", "year": 2024}, {"admitted": true, "circuit": "MDL", "citation_count": 0, "color": "#4a4a4a", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "MDL-2327", "introducing_party": "Defense", "is_isolated": false, "label": "MDL-2327: Geery v. Ethicon, Inc. (+6 more)", "practice_area": "Pharma tort", "shape": "dot", "size": 10, "title": "MDL 2327\nCases: Geery v. Ethicon, Inc., In re Ethicon, Inc. Pelvic Repair Sys. Prod. Liab. Litig., Mason v. Ethicon, Inc....\n[Order]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 6:20-CV-1975-RBD-LRH, 2:16-MD-2327-JRG, 6:20-CV-1078-RBD-DCI...\nYear: 2016-2022\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 2016}, {"admitted": true, "circuit": 1, "citation_count": 2, "color": "#e8d5a3", "document_type": "Opinion", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "MDL-1629", "introducing_party": "Plaintiff", "is_isolated": false, "label": "MDL-1629: Guardian Life Ins. Co. of Am. ... (+1 more)", "practice_area": "Pharma tort", "shape": "dot", "size": 16, "title": "MDL 1629\nCases: Guardian Life Ins. Co. of Am. v. Pfizer, Inc., In re: Neurontin Marketing, Sales Practices and Products Liability Litigation\n[Other document]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 04-CV-10981-PBS, 1:04-CV-10981-PBS\nYear: 2010-2011\nPractice area: Business/commercial, Pharma tort\nExpert discipline(s): Medicine", "year": 2010}, {"admitted": false, "circuit": 2, "citation_count": 1, "color": "#d4a574", "document_type": "Order", "expert_disciplines": "Epidemiology", "font": {"color": "black"}, "id": "In re Acetaminophen - ASD-ADHD Prods. Liab. Litig.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Acetaminophen - ASD-ADHD Prods. Liab. Litig.", "practice_area": "Pharma tort", "shape": "square", "size": 13, "title": "In re Acetaminophen - ASD-ADHD Prods. Liab. Litig.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 22-MD-3043-DLC\nYear: 2023\nPractice area: Pharma tort\nExpert discipline(s): Epidemiology", "year": 2023}, {"admitted": true, "circuit": 5, "citation_count": 1, "color": "#9c7ba6", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "In re Actos Prods. Liab. Litig.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Actos Prods. Liab. Litig.", "practice_area": "Pharma tort", "shape": "dot", "size": 13, "title": "In re Actos Prods. Liab. Litig.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 6:11-MD-2299-RFD\nYear: 2014\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 2014}, {"admitted": true, "circuit": 3, "citation_count": 1, "color": "#b8876b", "document_type": "Order", "expert_disciplines": "Interdisciplinary team", "font": {"color": "black"}, "id": "In re Avandia Mktg.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Avandia Mktg.", "practice_area": "Pharma tort", "shape": "dot", "size": 13, "title": "In re Avandia Mktg.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 07-MD-1871-CMR\nYear: 2011\nPractice area: Pharma tort\nExpert discipline(s): Interdisciplinary team", "year": 2011}, {"admitted": false, "circuit": 8, "citation_count": 3, "color": "#5d8e95", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "In re Baycol", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Baycol", "practice_area": "Pharma tort", "shape": "square", "size": 19, "title": "In re Baycol\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 07-MD-1431-MJD\nYear: 2007\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 2007}, {"admitted": true, "circuit": 9, "citation_count": 12, "color": "#5a9185", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "In re Bextra \u0026 Celebrex Mktg. Sales Practices \u0026 Prod. Liab. Litig.", "introducing_party": "Defense", "is_isolated": false, "label": "In re Bextra \u0026 Celebrex Mktg. Sales Practices \u0026 Pr...", "practice_area": "Pharma tort", "shape": "dot", "size": 46, "title": "In re Bextra \u0026 Celebrex Mktg. Sales Practices \u0026 Prod. Liab. Litig.\n[Order]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: M:05-CV-01699-CRB\nYear: 2007\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 2007}, {"admitted": true, "circuit": 8, "citation_count": 0, "color": "#5d8e95", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "In re Celexa \u0026 Lexapro Prods. Liab. Litig.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Celexa \u0026 Lexapro Prods. Liab. Litig.", "practice_area": "Pharma tort", "shape": "dot", "size": 10, "title": "In re Celexa \u0026 Lexapro Prods. Liab. Litig.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 13-MD-1736-RWS\nYear: 2013\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 2013}, {"admitted": true, "circuit": 7, "citation_count": 0, "color": "#6b8ba3", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "In re Cook Med., Inc.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Cook Med., Inc.", "practice_area": "Pharma tort", "shape": "dot", "size": 10, "title": "In re Cook Med., Inc.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 1:14-MD-2570-RLY-TAB\nYear: 2018\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 2018}, {"admitted": false, "circuit": 11, "citation_count": 0, "color": "#829565", "document_type": "Order", "expert_disciplines": "Interdisciplinary team", "font": {"color": "black"}, "id": "In re Deepwater Horizon Belo Cases", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Deepwater Horizon Belo Cases", "practice_area": "Toxic tort", "shape": "square", "size": 10, "title": "In re Deepwater Horizon Belo Cases\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 3:21-CV-3287\nYear: 2024\nPractice area: Toxic tort\nExpert discipline(s): Interdisciplinary team", "year": 2024}, {"admitted": true, "circuit": 2, "citation_count": 12, "color": "#d4a574", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "In re Fosamax", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Fosamax", "practice_area": "Pharma tort", "shape": "dot", "size": 46, "title": "In re Fosamax\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 1:06-MD-1789-JFK\nYear: 2009\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 2009}, {"admitted": true, "circuit": 6, "citation_count": 4, "color": "#7a82a8", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "In re Gadolinium-Based Contrast Agents Prods. Liab. Litig.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Gadolinium-Based Contrast Agents Prods. Liab...", "practice_area": "Pharma tort", "shape": "dot", "size": 22, "title": "In re Gadolinium-Based Contrast Agents Prods. Liab. Litig.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 1:08-MD-50000-DAP\nYear: 2010\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 2010}, {"admitted": false, "circuit": 9, "citation_count": 1, "color": "#5a9185", "document_type": "Order", "expert_disciplines": "Mathematics/statistics", "font": {"color": "black"}, "id": "In re Incretin-Based Therapies Prods. Liab. Litig.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Incretin-Based Therapies Prods. Liab. Litig.", "practice_area": "Pharma tort", "shape": "square", "size": 13, "title": "In re Incretin-Based Therapies Prods. Liab. Litig.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 13-MD-2452-AJB-MDD\nYear: 2021\nPractice area: Pharma tort\nExpert discipline(s): Mathematics/statistics", "year": 2021}, {"admitted": true, "circuit": 3, "citation_count": 3, "color": "#b8876b", "document_type": "Order", "expert_disciplines": "Interdisciplinary team", "font": {"color": "black"}, "id": "In re Johnson \u0026 Johnson Talcum Powder Prods. Mktg.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Johnson \u0026 Johnson Talcum Powder Prods. Mktg.", "practice_area": "Toxic tort", "shape": "dot", "size": 19, "title": "In re Johnson \u0026 Johnson Talcum Powder Prods. Mktg.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 16-MD-2738-FLW\nYear: 2020\nPractice area: Toxic tort\nExpert discipline(s): Interdisciplinary team", "year": 2020}, {"admitted": true, "circuit": 4, "citation_count": 1, "color": "#a67c7c", "document_type": "Opinion", "expert_disciplines": "Mathematics/statistics", "font": {"color": "black"}, "id": "In re Lipitor (Atorvastatin Calcium) Mktg., Sales Practices \u0026 Prods. Liab. Litig.", "introducing_party": "Defense", "is_isolated": false, "label": "In re Lipitor (Atorvastatin Calcium) Mktg., Sales ...", "practice_area": "Pharma tort", "shape": "dot", "size": 13, "title": "In re Lipitor (Atorvastatin Calcium) Mktg., Sales Practices \u0026 Prods. Liab. Litig.\n[Other document]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 2:14-MD-02502-RMG\nYear: 2015\nPractice area: Pharma tort\nExpert discipline(s): Mathematics/statistics", "year": 2015}, {"admitted": false, "circuit": 6, "citation_count": 0, "color": "#7a82a8", "document_type": "Order", "expert_disciplines": "Epidemiology", "font": {"color": "black"}, "id": "In re Nat\u0027l Prescription Opiate Litig.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Nat\u0027l Prescription Opiate Litig.", "practice_area": "Pharma tort", "shape": "square", "size": 10, "title": "In re Nat\u0027l Prescription Opiate Litig.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 1:17-MD-2804-DAP\nYear: 2019\nPractice area: Pharma tort\nExpert discipline(s): Epidemiology", "year": 2019}, {"admitted": true, "circuit": 6, "citation_count": 0, "color": "#7a82a8", "document_type": "Order", "expert_disciplines": "Interdisciplinary team", "font": {"color": "black"}, "id": "In re Onglyza (Saxagliptin) \u0026 Kombiglyze XR (Saxagliptin \u0026 Metformin) Prods. Liab. Litig.", "introducing_party": "Defense", "is_isolated": false, "label": "In re Onglyza (Saxagliptin) \u0026 Kombiglyze XR (Saxag...", "practice_area": "Pharma tort", "shape": "dot", "size": 10, "title": "In re Onglyza (Saxagliptin) \u0026 Kombiglyze XR (Saxagliptin \u0026 Metformin) Prods. Liab. Litig.\n[Order]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 5:18-MD-2809-KKC-MAS\nYear: 2022\nPractice area: Pharma tort\nExpert discipline(s): Interdisciplinary team", "year": 2022}, {"admitted": true, "circuit": 3, "citation_count": 0, "color": "#b8876b", "document_type": "Order", "expert_disciplines": "Mathematics/statistics, Medicine", "font": {"color": "black"}, "id": "In re Proton-Pump Inhibitor Prods. Liab. Litig.", "introducing_party": "Both", "is_isolated": false, "label": "In re Proton-Pump Inhibitor Prods. Liab. Litig.", "practice_area": "Pharma tort", "shape": "dot", "size": 10, "title": "In re Proton-Pump Inhibitor Prods. Liab. Litig.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted) and defendant(s) (admitted)\nCase number: 2:17-MD-2789\nYear: 2022\nPractice area: Pharma tort\nExpert discipline(s): Mathematics/statistics, Medicine", "year": 2022}, {"admitted": true, "circuit": 9, "citation_count": 3, "color": "#5a9185", "document_type": "Order", "expert_disciplines": "Interdisciplinary team, Medicine, Life sciences", "font": {"color": "black"}, "id": "In re Roundup Prods. Liab. Litig.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Roundup Prods. Liab. Litig.", "practice_area": "Toxic tort", "shape": "triangle", "size": 19, "title": "In re Roundup Prods. Liab. Litig.\n[Order]\nMeta-analysis introduced by plaintiff(s) (mixed)\nCase number: 16- MD-2741-VC\nYear: 2018\nPractice area: Toxic tort\nExpert discipline(s): Interdisciplinary team, Medicine, Life sciences", "year": 2018}, {"admitted": true, "circuit": 11, "citation_count": 3, "color": "#829565", "document_type": "Order", "expert_disciplines": "Epidemiology", "font": {"color": "black"}, "id": "In re Seroquel", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Seroquel", "practice_area": "Pharma tort", "shape": "dot", "size": 19, "title": "In re Seroquel\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 6:06-MD-1769-ACC\nYear: 2009\nPractice area: Pharma tort\nExpert discipline(s): Epidemiology", "year": 2009}, {"admitted": true, "circuit": 11, "citation_count": 0, "color": "#829565", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "In re Tasigna Nilotinib Prods. Liab. Litig.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Tasigna Nilotinib Prods. Liab. Litig.", "practice_area": "Pharma tort", "shape": "dot", "size": 10, "title": "In re Tasigna Nilotinib Prods. Liab. Litig.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 6:21-MD-3006-RBD-DAB\nYear: 2024\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 2024}, {"admitted": false, "circuit": 5, "citation_count": 0, "color": "#9c7ba6", "document_type": "Order", "expert_disciplines": "Mathematics/statistics", "font": {"color": "black"}, "id": "In re Taxotere (Docetaxel) Prods. Liab. Litig.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Taxotere (Docetaxel) Prods. Liab. Litig.", "practice_area": "Pharma tort", "shape": "square", "size": 10, "title": "In re Taxotere (Docetaxel) Prods. Liab. Litig.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 16-MD-2740-JTM\nYear: 2020\nPractice area: Pharma tort\nExpert discipline(s): Mathematics/statistics", "year": 2020}, {"admitted": true, "circuit": 7, "citation_count": 1, "color": "#6b8ba3", "document_type": "Order", "expert_disciplines": "Social sciences, Medicine, Epidemiology", "font": {"color": "black"}, "id": "In re Testosterone Replacement Therapy Prods. Liab. Litig.", "introducing_party": "Both", "is_isolated": false, "label": "In re Testosterone Replacement Therapy Prods. Liab...", "practice_area": "Pharma tort", "shape": "dot", "size": 13, "title": "In re Testosterone Replacement Therapy Prods. Liab. Litig.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted) and defendant(s) (admitted)\nCase number: 1:14-MD-2545-MFK\nYear: 2017\nPractice area: Pharma tort\nExpert discipline(s): Social sciences, Medicine, Epidemiology", "year": 2017}, {"admitted": false, "circuit": 9, "citation_count": 4, "color": "#5a9185", "document_type": "Order", "expert_disciplines": "Interdisciplinary team", "font": {"color": "black"}, "id": "In re Viagra (Sildenafil Citrate) \u0026 Cialis (Tadalafil)", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Viagra (Sildenafil Citrate) \u0026 Cialis (Tadala...", "practice_area": "Pharma tort", "shape": "square", "size": 22, "title": "In re Viagra (Sildenafil Citrate) \u0026 Cialis (Tadalafil)\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 16-MD-02691-RS\nYear: 2020\nPractice area: Pharma tort\nExpert discipline(s): Interdisciplinary team", "year": 2020}, {"admitted": false, "circuit": 11, "citation_count": 3, "color": "#829565", "document_type": "Order", "expert_disciplines": "Epidemiology", "font": {"color": "black"}, "id": "In re Zantac (Ranitidine) Prods. Liab. Litig.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Zantac (Ranitidine) Prods. Liab. Litig.", "practice_area": "Pharma tort", "shape": "square", "size": 19, "title": "In re Zantac (Ranitidine) Prods. Liab. Litig.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 9:20-MD-02924-RLR\nYear: 2022\nPractice area: Pharma tort\nExpert discipline(s): Epidemiology", "year": 2022}, {"admitted": true, "circuit": 7, "citation_count": 2, "color": "#6b8ba3", "document_type": "Both", "expert_disciplines": "Mathematics/statistics, Medicine", "font": {"color": "black"}, "id": "MDL-2272", "introducing_party": "Both", "is_isolated": false, "label": "MDL-2272: In re Zimmer NexGen Knee Impla... (+1 more)", "practice_area": "Pharma tort", "shape": "triangle", "size": 16, "title": "MDL 2272\nCases: In re Zimmer NexGen Knee Implant, In re Zimmer Nexgen Knee Implant Prods. Liab. Litig.\n[Order \u0026 Other document]\nMeta-analysis introduced by plaintiff(s) (excluded) and defendant(s) (admitted)\nCase number: 1:11-CV-05468-RRP\nYear: 2015-2016\nPractice area: Pharma tort\nExpert discipline(s): Mathematics/statistics, Medicine", "year": 2015}, {"admitted": false, "circuit": 3, "citation_count": 10, "color": "#b8876b", "document_type": "Order", "expert_disciplines": "Mathematics/statistics", "font": {"color": "black"}, "id": "In re Zoloft (Sertraline Hydrochloride) Prods. Liab. Litig.", "introducing_party": "Plaintiff", "is_isolated": false, "label": "In re Zoloft (Sertraline Hydrochloride) Prods. Lia...", "practice_area": "Pharma tort", "shape": "square", "size": 40, "title": "In re Zoloft (Sertraline Hydrochloride) Prods. Liab. Litig.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 2:12-MD-2342-CMR\nYear: 2015\nPractice area: Pharma tort\nExpert discipline(s): Mathematics/statistics", "year": 2015}, {"admitted": false, "circuit": 7, "citation_count": 0, "color": "#6b8ba3", "document_type": "Order", "expert_disciplines": "Mathematics/statistics", "font": {"color": "black"}, "id": "Richter v. Syngenta AG (In re Paraquat Prods. Liab. Litig.)", "introducing_party": "Plaintiff", "is_isolated": false, "label": "Richter v. Syngenta AG (In re Paraquat Prods. Liab...", "practice_area": "Toxic tort", "shape": "square", "size": 10, "title": "Richter v. Syngenta AG (In re Paraquat Prods. Liab. Litig.)\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 3:21-MD-3004-NJR\nYear: 2024\nPractice area: Toxic tort\nExpert discipline(s): Mathematics/statistics", "year": 2024}, {"admitted": true, "circuit": 7, "citation_count": 0, "color": "#6b8ba3", "document_type": "Opinion", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "Adams v. City of Chicago", "introducing_party": "Defense", "is_isolated": true, "label": "Adams v. City of Chicago", "practice_area": "Constitutional/civil rights", "shape": "dot", "size": 8, "title": "Adams v. City of Chicago\n[Other document]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 1:94-CV-05727\nYear: 1996\nPractice area: Constitutional/civil rights\nExpert discipline(s): Psychology", "year": 1996}, {"admitted": true, "circuit": 3, "citation_count": 0, "color": "#b8876b", "document_type": "Opinion", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Araoz v. United States", "introducing_party": "Defense", "is_isolated": true, "label": "Araoz v. United States", "practice_area": "Other civil suit", "shape": "dot", "size": 8, "title": "Araoz v. United States\n[Other document]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 06-CV-2149-FSH\nYear: 2008\nPractice area: Other civil suit\nExpert discipline(s): Medicine", "year": 2008}, {"admitted": true, "circuit": 5, "citation_count": 0, "color": "#9c7ba6", "document_type": "Opinion", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "Bazile v. City of Houston", "introducing_party": "Defense", "is_isolated": true, "label": "Bazile v. City of Houston", "practice_area": "Constitutional/civil rights", "shape": "dot", "size": 8, "title": "Bazile v. City of Houston\n[Other document]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: H:08-CV-2404-LHR\nYear: 2012\nPractice area: Constitutional/civil rights\nExpert discipline(s): Psychology", "year": 2012}, {"admitted": false, "circuit": 4, "citation_count": 0, "color": "#a67c7c", "document_type": "Opinion", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Bishop v. Office of Civilian Health \u0026 Medical Programs of the Uniformed Servs.", "introducing_party": "Defense", "is_isolated": true, "label": "Bishop v. Office of Civilian Health \u0026 Medical Prog...", "practice_area": "Other civil suit", "shape": "square", "size": 8, "title": "Bishop v. Office of Civilian Health \u0026 Medical Programs of the Uniformed Servs.\n[Other document]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: CS-96-0045-AAM\nYear: 1996\nPractice area: Other civil suit\nExpert discipline(s): Medicine", "year": 1996}, {"admitted": false, "circuit": 4, "citation_count": 0, "color": "#a67c7c", "document_type": "Order", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "Black v. Rhone-Poulenc, Inc.", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Black v. Rhone-Poulenc, Inc.", "practice_area": "Toxic tort", "shape": "square", "size": 8, "title": "Black v. Rhone-Poulenc, Inc.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 2:96-CV-0163-CHH\nYear: 1998\nPractice area: Toxic tort\nExpert discipline(s): Psychology", "year": 1998}, {"admitted": true, "circuit": 7, "citation_count": 0, "color": "#6b8ba3", "document_type": "Order", "expert_disciplines": "Interdisciplinary team", "font": {"color": "black"}, "id": "Boyer v. Weyerhaeuser Company", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Boyer v. Weyerhaeuser Company", "practice_area": "Toxic tort", "shape": "dot", "size": 8, "title": "Boyer v. Weyerhaeuser Company\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 14-CV-286-WMC\nYear: 2016\nPractice area: Toxic tort\nExpert discipline(s): Interdisciplinary team", "year": 2016}, {"admitted": true, "circuit": 3, "citation_count": 0, "color": "#b8876b", "document_type": "Opinion", "expert_disciplines": "Mathematics/statistics, Medicine", "font": {"color": "black"}, "id": "Bracco Diagnostics, Inc. v. Amersham Health, Inc.", "introducing_party": "Both", "is_isolated": true, "label": "Bracco Diagnostics, Inc. v. Amersham Health, Inc.", "practice_area": "Business/commercial", "shape": "triangle", "size": 8, "title": "Bracco Diagnostics, Inc. v. Amersham Health, Inc.\n[Other document]\nMeta-analysis introduced by plaintiff(s) (admitted) and defendant(s) (excluded)\nCase number: 03-CV-6025-FLW\nYear: 2009\nPractice area: Business/commercial\nExpert discipline(s): Mathematics/statistics, Medicine", "year": 2009}, {"admitted": true, "circuit": 9, "citation_count": 0, "color": "#5a9185", "document_type": "Opinion", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Bradach v. Pharmavite LLC", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Bradach v. Pharmavite LLC", "practice_area": "Business/commercial", "shape": "dot", "size": 8, "title": "Bradach v. Pharmavite LLC\n[Other document]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 14-CV-3218-GHK\nYear: 2015\nPractice area: Business/commercial\nExpert discipline(s): Medicine", "year": 2015}, {"admitted": true, "circuit": 6, "citation_count": 0, "color": "#7a82a8", "document_type": "Opinion", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Brown v. United States", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Brown v. United States", "practice_area": "Other civil suit", "shape": "dot", "size": 8, "title": "Brown v. United States\n[Other document]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 2:03-CV-2282-JPM-STA\nYear: 2007\nPractice area: Other civil suit\nExpert discipline(s): Medicine", "year": 2007}, {"admitted": false, "circuit": 3, "citation_count": 0, "color": "#b8876b", "document_type": "Opinion", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Chamber of Commerce for Greater Phila. v. City of Phila.", "introducing_party": "Defense", "is_isolated": true, "label": "Chamber of Commerce for Greater Phila. v. City of ...", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 8, "title": "Chamber of Commerce for Greater Phila. v. City of Phila.\n[Other document]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: 17-CV-1548-MSG\nYear: 2018\nPractice area: Constitutional/civil rights\nExpert discipline(s): Social sciences", "year": 2018}, {"admitted": true, "circuit": 2, "citation_count": 0, "color": "#d4a574", "document_type": "Order", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "Chen-Oster v. Goldman, Sachs \u0026 Co", "introducing_party": "Defense", "is_isolated": true, "label": "Chen-Oster v. Goldman, Sachs \u0026 Co", "practice_area": "Constitutional/civil rights", "shape": "dot", "size": 8, "title": "Chen-Oster v. Goldman, Sachs \u0026 Co\n[Order]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 10-CV-6950-JCF\nYear: 2015\nPractice area: Constitutional/civil rights\nExpert discipline(s): Psychology", "year": 2015}, {"admitted": true, "circuit": 3, "citation_count": 0, "color": "#b8876b", "document_type": "Opinion", "expert_disciplines": "Life sciences", "font": {"color": "black"}, "id": "Christ\u0027s Bride Ministries v. SEPTA", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Christ\u0027s Bride Ministries v. SEPTA", "practice_area": "Constitutional/civil rights", "shape": "dot", "size": 8, "title": "Christ\u0027s Bride Ministries v. SEPTA\n[Other document]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 96-CV-1829-HB\nYear: 1996\nPractice area: Constitutional/civil rights\nExpert discipline(s): Life sciences", "year": 1996}, {"admitted": true, "circuit": 11, "citation_count": 0, "color": "#829565", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Cotromano v. United Techs. Corp.", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Cotromano v. United Techs. Corp.", "practice_area": "Toxic tort", "shape": "dot", "size": 8, "title": "Cotromano v. United Techs. Corp.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 13-CV-80928-KAM;13-CV-80840-KAM\nYear: 2020\nPractice area: Toxic tort\nExpert discipline(s): Social sciences", "year": 2020}, {"admitted": false, "circuit": 9, "citation_count": 0, "color": "#5a9185", "document_type": "Opinion", "expert_disciplines": "Life sciences", "font": {"color": "black"}, "id": "Doe v. Horne", "introducing_party": "Defense", "is_isolated": true, "label": "Doe v. Horne", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 8, "title": "Doe v. Horne\n[Other document]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: 23-CV-00185-TUC-JGZ\nYear: 2023\nPractice area: Constitutional/civil rights\nExpert discipline(s): Life sciences", "year": 2023}, {"admitted": true, "circuit": 8, "citation_count": 0, "color": "#5d8e95", "document_type": "Opinion", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "Doe v. Miller", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Doe v. Miller", "practice_area": "Constitutional/civil rights", "shape": "dot", "size": 8, "title": "Doe v. Miller\n[Other document]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 3:03-CV-90067-RWP\nYear: 2004\nPractice area: Constitutional/civil rights\nExpert discipline(s): Psychology", "year": 2004}, {"admitted": true, "circuit": 9, "citation_count": 0, "color": "#5a9185", "document_type": "Opinion", "expert_disciplines": "Epidemiology", "font": {"color": "black"}, "id": "Escalante v. Cal. Physicians\u0027 Serv.", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Escalante v. Cal. Physicians\u0027 Serv.", "practice_area": "Other civil suit", "shape": "dot", "size": 8, "title": "Escalante v. Cal. Physicians\u0027 Serv.\n[Other document]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 2:14-CV-3021-DDP\nYear: 2016\nPractice area: Other civil suit\nExpert discipline(s): Epidemiology", "year": 2016}, {"admitted": true, "circuit": 7, "citation_count": 0, "color": "#6b8ba3", "document_type": "Order", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "Ezell v. City of Chicago", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Ezell v. City of Chicago", "practice_area": "Constitutional/civil rights", "shape": "dot", "size": 8, "title": "Ezell v. City of Chicago\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 1:18-CV-01049-SLE\nYear: 2023\nPractice area: Constitutional/civil rights\nExpert discipline(s): Psychology", "year": 2023}, {"admitted": true, "circuit": 10, "citation_count": 0, "color": "#6b9174", "document_type": "Opinion", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Fish v. Kobach", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Fish v. Kobach", "practice_area": "Constitutional/civil rights", "shape": "triangle", "size": 8, "title": "Fish v. Kobach\n[Other document]\nMeta-analysis introduced by plaintiff(s) (mixed)\nCase number: 16-CV-2105-JAR-JPO\nYear: 2018\nPractice area: Constitutional/civil rights\nExpert discipline(s): Social sciences", "year": 2018}, {"admitted": true, "circuit": 11, "citation_count": 0, "color": "#829565", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Floyd v. United States", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Floyd v. United States", "practice_area": "Other civil suit", "shape": "dot", "size": 8, "title": "Floyd v. United States\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 3:08-CV-122-CDL\nYear: 2010\nPractice area: Other civil suit\nExpert discipline(s): Medicine", "year": 2010}, {"admitted": true, "circuit": 9, "citation_count": 0, "color": "#5a9185", "document_type": "Order", "expert_disciplines": "Life sciences, Epidemiology", "font": {"color": "black"}, "id": "Food \u0026 Water Watch, Inc. v. United States EPA", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Food \u0026 Water Watch, Inc. v. United States EPA", "practice_area": "Toxic tort", "shape": "dot", "size": 8, "title": "Food \u0026 Water Watch, Inc. v. United States EPA\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 17-CV-02162-EMC\nYear: 2024\nPractice area: Toxic tort\nExpert discipline(s): Life sciences, Epidemiology", "year": 2024}, {"admitted": true, "circuit": 3, "citation_count": 0, "color": "#b8876b", "document_type": "Order", "expert_disciplines": "Mathematics/statistics", "font": {"color": "black"}, "id": "Forest Labs., Inc. v. Ivex Pharms., Inc.", "introducing_party": "Defense", "is_isolated": true, "label": "Forest Labs., Inc. v. Ivex Pharms., Inc.", "practice_area": "Pharma tort", "shape": "dot", "size": 8, "title": "Forest Labs., Inc. v. Ivex Pharms., Inc.\n[Order]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 03-CV-891-JJF\nYear: 2006\nPractice area: Pharma tort\nExpert discipline(s): Mathematics/statistics", "year": 2006}, {"admitted": false, "circuit": 4, "citation_count": 0, "color": "#a67c7c", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Good v. Am. Water Works Co.", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Good v. Am. Water Works Co.", "practice_area": "Toxic tort", "shape": "square", "size": 8, "title": "Good v. Am. Water Works Co.\n[Order]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 2:14-CV-01374-JTC\nYear: 2015\nPractice area: Toxic tort\nExpert discipline(s): Social sciences", "year": 2015}, {"admitted": true, "circuit": 11, "citation_count": 0, "color": "#829565", "document_type": "Opinion", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "K.G. v. Dudek", "introducing_party": "Plaintiff", "is_isolated": true, "label": "K.G. v. Dudek", "practice_area": "Other civil suit", "shape": "dot", "size": 8, "title": "K.G. v. Dudek\n[Other document]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 11-CV-20684-JAL\nYear: 2013\nPractice area: Other civil suit\nExpert discipline(s): Psychology", "year": 2013}, {"admitted": true, "circuit": 7, "citation_count": 0, "color": "#6b8ba3", "document_type": "Opinion", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Kasongo v. United States", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Kasongo v. United States", "practice_area": "Other civil suit", "shape": "dot", "size": 8, "title": "Kasongo v. United States\n[Other document]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 04-CV-4901-RRP\nYear: 2007\nPractice area: Other civil suit\nExpert discipline(s): Medicine", "year": 2007}, {"admitted": true, "circuit": 6, "citation_count": 0, "color": "#7a82a8", "document_type": "Opinion", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "King v. Ohio", "introducing_party": "Plaintiff", "is_isolated": true, "label": "King v. Ohio", "practice_area": "Constitutional/civil rights", "shape": "dot", "size": 8, "title": "King v. Ohio\n[Other document]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 2:05-CV-966-NMK\nYear: 2009\nPractice area: Constitutional/civil rights\nExpert discipline(s): Psychology", "year": 2009}, {"admitted": true, "circuit": 5, "citation_count": 0, "color": "#9c7ba6", "document_type": "Opinion", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "LeBlanc v. Merrell Dow Pharms.", "introducing_party": "Defense", "is_isolated": true, "label": "LeBlanc v. Merrell Dow Pharms.", "practice_area": "Pharma tort", "shape": "dot", "size": 8, "title": "LeBlanc v. Merrell Dow Pharms.\n[Other document]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: L:95-CV-193-ECF\nYear: 1996\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 1996}, {"admitted": false, "circuit": 7, "citation_count": 0, "color": "#6b8ba3", "document_type": "Opinion", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "Lewis v. City of Chicago", "introducing_party": "Defense", "is_isolated": true, "label": "Lewis v. City of Chicago", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 8, "title": "Lewis v. City of Chicago\n[Other document]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: 1:98-CV-05596\nYear: 2005\nPractice area: Constitutional/civil rights\nExpert discipline(s): Psychology", "year": 2005}, {"admitted": true, "circuit": 4, "citation_count": 0, "color": "#a67c7c", "document_type": "Order", "expert_disciplines": "Interdisciplinary team", "font": {"color": "black"}, "id": "Lightfoot v. Georgia-Pacific Wood Prods., LLC", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Lightfoot v. Georgia-Pacific Wood Prods., LLC", "practice_area": "Toxic tort", "shape": "dot", "size": 8, "title": "Lightfoot v. Georgia-Pacific Wood Prods., LLC\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 7:16-CV-244-LF\nYear: 2018\nPractice area: Toxic tort\nExpert discipline(s): Interdisciplinary team", "year": 2018}, {"admitted": false, "circuit": 8, "citation_count": 0, "color": "#5d8e95", "document_type": "Opinion", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Little Rock Family Planning Services v. Rutledge", "introducing_party": "Defense", "is_isolated": true, "label": "Little Rock Family Planning Services v. Rutledge", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 8, "title": "Little Rock Family Planning Services v. Rutledge\n[Other document]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: 4:19-CV-00449-KGB\nYear: 2019\nPractice area: Constitutional/civil rights\nExpert discipline(s): Medicine", "year": 2019}, {"admitted": true, "circuit": 7, "citation_count": 0, "color": "#6b8ba3", "document_type": "Opinion", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "McConchie v. Scholz", "introducing_party": "Plaintiff", "is_isolated": true, "label": "McConchie v. Scholz", "practice_area": "Constitutional/civil rights", "shape": "dot", "size": 8, "title": "McConchie v. Scholz\n[Other document]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 21-CV-3091-MBB\nYear: 2021\nPractice area: Constitutional/civil rights\nExpert discipline(s): Social sciences", "year": 2021}, {"admitted": false, "circuit": 11, "citation_count": 0, "color": "#829565", "document_type": "Opinion", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "McGuire v. Marshall", "introducing_party": "Defense", "is_isolated": true, "label": "McGuire v. Marshall", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 8, "title": "McGuire v. Marshall\n[Other document]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: 2:19-CV-174-WKW\nYear: 2024\nPractice area: Constitutional/civil rights\nExpert discipline(s): Social sciences", "year": 2024}, {"admitted": true, "circuit": 9, "citation_count": 0, "color": "#5a9185", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Montgomery v. Union Pac. R.R. Co.", "introducing_party": "Defense", "is_isolated": true, "label": "Montgomery v. Union Pac. R.R. Co.", "practice_area": "Constitutional/civil rights", "shape": "dot", "size": 8, "title": "Montgomery v. Union Pac. R.R. Co.\n[Order]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 17-CV-00201-RM\nYear: 2019\nPractice area: Constitutional/civil rights\nExpert discipline(s): Medicine", "year": 2019}, {"admitted": true, "circuit": 7, "citation_count": 0, "color": "#6b8ba3", "document_type": "Order", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "N.J. v. Sonnabend", "introducing_party": "Defense", "is_isolated": true, "label": "N.J. v. Sonnabend", "practice_area": "Constitutional/civil rights", "shape": "dot", "size": 8, "title": "N.J. v. Sonnabend\n[Order]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 20-CV-227-WCG\nYear: 2021\nPractice area: Constitutional/civil rights\nExpert discipline(s): Psychology", "year": 2021}, {"admitted": true, "circuit": 7, "citation_count": 0, "color": "#6b8ba3", "document_type": "Order", "expert_disciplines": "Epidemiology", "font": {"color": "black"}, "id": "NRDC v. Ill. Power Res. Generating, LLC", "introducing_party": "Plaintiff", "is_isolated": true, "label": "NRDC v. Ill. Power Res. Generating, LLC", "practice_area": "Toxic tort", "shape": "dot", "size": 8, "title": "NRDC v. Ill. Power Res. Generating, LLC\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 1:13-CV-1181-JBM\nYear: 2018\nPractice area: Toxic tort\nExpert discipline(s): Epidemiology", "year": 2018}, {"admitted": true, "circuit": 4, "citation_count": 0, "color": "#a67c7c", "document_type": "Opinion", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Nelson v. Warner", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Nelson v. Warner", "practice_area": "Constitutional/civil rights", "shape": "dot", "size": 8, "title": "Nelson v. Warner\n[Other document]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 3:19-CV-0898-RCC\nYear: 2020\nPractice area: Constitutional/civil rights\nExpert discipline(s): Social sciences", "year": 2020}, {"admitted": true, "circuit": 9, "citation_count": 0, "color": "#5a9185", "document_type": "Opinion", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Ritchie v. United States", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Ritchie v. United States", "practice_area": "Other civil suit", "shape": "dot", "size": 8, "title": "Ritchie v. United States\n[Other document]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 00-CV-03940-MHP\nYear: 2004\nPractice area: Other civil suit\nExpert discipline(s): Medicine", "year": 2004}, {"admitted": true, "circuit": 10, "citation_count": 0, "color": "#6b9174", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Safe Streets Alliance v. Alternative Holistic Healing, LLC", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Safe Streets Alliance v. Alternative Holistic Heal...", "practice_area": "Business/commercial", "shape": "dot", "size": 8, "title": "Safe Streets Alliance v. Alternative Holistic Healing, LLC\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 15-CV-00349-REB-SKC\nYear: 2018\nPractice area: Business/commercial\nExpert discipline(s): Social sciences", "year": 2018}, {"admitted": true, "circuit": 6, "citation_count": 0, "color": "#7a82a8", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Satija v. Permanent Gen. Assur. Corp.", "introducing_party": "Defense", "is_isolated": true, "label": "Satija v. Permanent Gen. Assur. Corp.", "practice_area": "Business/commercial", "shape": "dot", "size": 8, "title": "Satija v. Permanent Gen. Assur. Corp.\n[Order]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 1:13-CV-00082-JSG\nYear: 2014\nPractice area: Business/commercial\nExpert discipline(s): Social sciences", "year": 2014}, {"admitted": false, "circuit": 3, "citation_count": 0, "color": "#b8876b", "document_type": "Opinion", "expert_disciplines": "Mathematics/statistics", "font": {"color": "black"}, "id": "Senju Pharm. Co. v. Apotex Inc.", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Senju Pharm. Co. v. Apotex Inc.", "practice_area": "Business/commercial", "shape": "square", "size": 8, "title": "Senju Pharm. Co. v. Apotex Inc.\n[Other document]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 07-CV-779-SLR\nYear: 2011\nPractice area: Business/commercial\nExpert discipline(s): Mathematics/statistics", "year": 2011}, {"admitted": false, "circuit": 1, "citation_count": 0, "color": "#e8d5a3", "document_type": "Opinion", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "Smith v. City of Boston", "introducing_party": "Defense", "is_isolated": true, "label": "Smith v. City of Boston", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 8, "title": "Smith v. City of Boston\n[Other document]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: 12-CV-10291-WGY\nYear: 2015\nPractice area: Constitutional/civil rights\nExpert discipline(s): Psychology", "year": 2015}, {"admitted": false, "circuit": 9, "citation_count": 0, "color": "#5a9185", "document_type": "Opinion", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Tracy Rifle \u0026 Pistol LLC v. Harris", "introducing_party": "Defense", "is_isolated": true, "label": "Tracy Rifle \u0026 Pistol LLC v. Harris", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 8, "title": "Tracy Rifle \u0026 Pistol LLC v. Harris\n[Other document]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: 2:14-CV-02626-TLN-DB\nYear: 2018\nPractice area: Constitutional/civil rights\nExpert discipline(s): Social sciences", "year": 2018}, {"admitted": true, "circuit": 8, "citation_count": 0, "color": "#5d8e95", "document_type": "Opinion", "expert_disciplines": "Epidemiology", "font": {"color": "black"}, "id": "United States v. Ameren Mo.", "introducing_party": "Plaintiff", "is_isolated": true, "label": "United States v. Ameren Mo.", "practice_area": "Other civil suit", "shape": "dot", "size": 8, "title": "United States v. Ameren Mo.\n[Other document]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 4:1- CV-77-RWS\nYear: 2019\nPractice area: Other civil suit\nExpert discipline(s): Epidemiology", "year": 2019}, {"admitted": true, "circuit": 2, "citation_count": 0, "color": "#d4a574", "document_type": "Opinion", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "United States v. Arena", "introducing_party": "Defense", "is_isolated": true, "label": "United States v. Arena", "practice_area": "Criminal", "shape": "dot", "size": 8, "title": "United States v. Arena\n[Other document]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 21-CR-671-MWP\nYear: 2023\nPractice area: Criminal\nExpert discipline(s): Medicine", "year": 2023}, {"admitted": false, "circuit": 2, "citation_count": 0, "color": "#d4a574", "document_type": "Opinion", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "United States v. C.R.", "introducing_party": "Defense", "is_isolated": true, "label": "United States v. C.R.", "practice_area": "Criminal", "shape": "square", "size": 8, "title": "United States v. C.R.\n[Other document]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: 09-CR-155-JBW\nYear: 2011\nPractice area: Criminal\nExpert discipline(s): Psychology", "year": 2011}, {"admitted": true, "circuit": 10, "citation_count": 0, "color": "#6b9174", "document_type": "Order", "expert_disciplines": "Life sciences", "font": {"color": "black"}, "id": "United States v. DeLeon", "introducing_party": "Defense", "is_isolated": true, "label": "United States v. DeLeon", "practice_area": "Criminal", "shape": "dot", "size": 8, "title": "United States v. DeLeon\n[Order]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 15-CR-4268-JOB\nYear: 2021\nPractice area: Criminal\nExpert discipline(s): Life sciences", "year": 2021}, {"admitted": true, "circuit": 2, "citation_count": 0, "color": "#d4a574", "document_type": "Opinion", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "United States v. Fell", "introducing_party": "Defense", "is_isolated": true, "label": "United States v. Fell", "practice_area": "Criminal", "shape": "dot", "size": 8, "title": "United States v. Fell\n[Other document]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 5:01-CR-1201-GWC\nYear: 2016\nPractice area: Criminal\nExpert discipline(s): Psychology", "year": 2016}, {"admitted": false, "circuit": 2, "citation_count": 0, "color": "#d4a574", "document_type": "Opinion", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "United States v. Hardy", "introducing_party": "Defense", "is_isolated": true, "label": "United States v. Hardy", "practice_area": "Criminal", "shape": "square", "size": 8, "title": "United States v. Hardy\n[Other document]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: C:93-CR-381-HGB\nYear: 2010\nPractice area: Criminal\nExpert discipline(s): Psychology", "year": 2010}, {"admitted": false, "circuit": 10, "citation_count": 0, "color": "#6b9174", "document_type": "Opinion", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "United States v. Streett", "introducing_party": "Defense", "is_isolated": true, "label": "United States v. Streett", "practice_area": "Criminal", "shape": "square", "size": 8, "title": "United States v. Streett\n[Other document]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: 22-CR-2056-JOB\nYear: 2020\nPractice area: Criminal\nExpert discipline(s): Medicine", "year": 2020}, {"admitted": false, "circuit": 4, "citation_count": 0, "color": "#a67c7c", "document_type": "Opinion", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "United States v. Virginia", "introducing_party": "Plaintiff", "is_isolated": true, "label": "United States v. Virginia", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 8, "title": "United States v. Virginia\n[Other document]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: R:90-CV-0126-JLK\nYear: 1994\nPractice area: Constitutional/civil rights\nExpert discipline(s): Psychology", "year": 1994}, {"admitted": true, "circuit": 9, "citation_count": 0, "color": "#5a9185", "document_type": "Opinion", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "Valle v. Scribner", "introducing_party": "Defense", "is_isolated": true, "label": "Valle v. Scribner", "practice_area": "Constitutional/civil rights", "shape": "dot", "size": 8, "title": "Valle v. Scribner\n[Other document]\nMeta-analysis introduced by defendant(s) (admitted)\nCase number: 08-CV-2330-AHM\nYear: 2010\nPractice area: Constitutional/civil rights\nExpert discipline(s): Psychology", "year": 2010}, {"admitted": true, "circuit": 11, "citation_count": 0, "color": "#829565", "document_type": "Order", "expert_disciplines": "Social sciences", "font": {"color": "black"}, "id": "Walker v. Yamaha Motor Co.", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Walker v. Yamaha Motor Co.", "practice_area": "Other civil suit", "shape": "dot", "size": 8, "title": "Walker v. Yamaha Motor Co.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 6:13-CV-1546-ORL-37-RBD-GJK\nYear: 2016\nPractice area: Other civil suit\nExpert discipline(s): Social sciences", "year": 2016}, {"admitted": false, "circuit": 7, "citation_count": 0, "color": "#6b8ba3", "document_type": "Opinion", "expert_disciplines": "Psychology", "font": {"color": "black"}, "id": "Whole Woman\u0027s Health Alliance v. Hill", "introducing_party": "Defense", "is_isolated": true, "label": "Whole Woman\u0027s Health Alliance v. Hill", "practice_area": "Constitutional/civil rights", "shape": "square", "size": 8, "title": "Whole Woman\u0027s Health Alliance v. Hill\n[Other document]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: 1:18-CV-01904-SEB-MJD\nYear: 2020\nPractice area: Constitutional/civil rights\nExpert discipline(s): Psychology", "year": 2020}, {"admitted": true, "circuit": 6, "citation_count": 0, "color": "#7a82a8", "document_type": "Opinion", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Williamson v. United States", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Williamson v. United States", "practice_area": "Other civil suit", "shape": "dot", "size": 8, "title": "Williamson v. United States\n[Other document]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 5:12-CV-334-JMH-REW\nYear: 2016\nPractice area: Other civil suit\nExpert discipline(s): Medicine", "year": 2016}, {"admitted": false, "circuit": 4, "citation_count": 0, "color": "#a67c7c", "document_type": "Opinion", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Yates v. Ford Motor Co", "introducing_party": "Defense", "is_isolated": true, "label": "Yates v. Ford Motor Co", "practice_area": "Toxic tort", "shape": "square", "size": 8, "title": "Yates v. Ford Motor Co\n[Other document]\nMeta-analysis introduced by defendant(s) (excluded)\nCase number: 5:12-CV-752-FL\nYear: 2015\nPractice area: Toxic tort\nExpert discipline(s): Medicine", "year": 2015}, {"admitted": false, "circuit": 2, "citation_count": 0, "color": "#d4a574", "document_type": "Opinion", "expert_disciplines": "Epidemiology", "font": {"color": "black"}, "id": "In re Joint E. \u0026 S. Dist. Asbestos Litig.", "introducing_party": "Plaintiff", "is_isolated": true, "label": "In re Joint E. \u0026 S. Dist. Asbestos Litig.", "practice_area": "Toxic tort", "shape": "square", "size": 8, "title": "In re Joint E. \u0026 S. Dist. Asbestos Litig.\n[Other document]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 88-MD-3317-RWS\nYear: 1993\nPractice area: Toxic tort\nExpert discipline(s): Epidemiology", "year": 1993}, {"admitted": true, "circuit": 10, "citation_count": 0, "color": "#6b9174", "document_type": "Order", "expert_disciplines": "Epidemiology", "font": {"color": "black"}, "id": "In re Santa Fe Nat. Tobacco Co. Mktg. \u0026 Sales Practices \u0026 Prods. Liab. Litig.", "introducing_party": "Plaintiff", "is_isolated": true, "label": "In re Santa Fe Nat. Tobacco Co. Mktg. \u0026 Sales Prac...", "practice_area": "Business/commercial", "shape": "dot", "size": 8, "title": "In re Santa Fe Nat. Tobacco Co. Mktg. \u0026 Sales Practices \u0026 Prods. Liab. Litig.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 16-MD-2695-JOB\nYear: 2023\nPractice area: Business/commercial\nExpert discipline(s): Epidemiology", "year": 2023}, {"admitted": true, "circuit": 7, "citation_count": 0, "color": "#6b8ba3", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "In re Yasmin \u0026 Yaz Mktg., Sales Practices \u0026 Prods. Litig.", "introducing_party": "Plaintiff", "is_isolated": true, "label": "In re Yasmin \u0026 Yaz Mktg., Sales Practices \u0026 Prods....", "practice_area": "Pharma tort", "shape": "dot", "size": 8, "title": "In re Yasmin \u0026 Yaz Mktg., Sales Practices \u0026 Prods. Litig.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 3:09-MD-2100-DRH\nYear: 2011\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 2011}, {"admitted": true, "circuit": 5, "citation_count": 0, "color": "#9c7ba6", "document_type": "Order", "expert_disciplines": "Medicine", "font": {"color": "black"}, "id": "Levitt v. Merck Sharp \u0026 Dohme Corp.", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Levitt v. Merck Sharp \u0026 Dohme Corp.", "practice_area": "Pharma tort", "shape": "dot", "size": 8, "title": "Levitt v. Merck Sharp \u0026 Dohme Corp.\n[Order]\nMeta-analysis introduced by plaintiff(s) (admitted)\nCase number: 16-MD-1657-EEF\nYear: 2016\nPractice area: Pharma tort\nExpert discipline(s): Medicine", "year": 2016}, {"admitted": false, "circuit": 1, "citation_count": 0, "color": "#e8d5a3", "document_type": "Opinion", "expert_disciplines": "Epidemiology", "font": {"color": "black"}, "id": "Longtin v. Organon USA, Inc.", "introducing_party": "Plaintiff", "is_isolated": true, "label": "Longtin v. Organon USA, Inc.", "practice_area": "Pharma tort", "shape": "square", "size": 8, "title": "Longtin v. Organon USA, Inc.\n[Other document]\nMeta-analysis introduced by plaintiff(s) (excluded)\nCase number: 15-CV-30014-MGM\nYear: 2018\nPractice area: Pharma tort\nExpert discipline(s): Epidemiology", "year": 2018}]);
                  edges = new vis.DataSet([{"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Testosterone Replacement Therapy Prods. Liab. Litig.", "to": "Magistrini v. One Hour Martinizing Dry Cleaning", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Taxotere (Docetaxel) Prods. Liab. Litig.", "to": "Knight v. Kirby Inland Marine, Inc.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Johnson \u0026 Johnson Talcum Powder Prods. Mktg.", "to": "Berg v. Johnson \u0026 Johnson Consumer Cos.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Lipitor (Atorvastatin Calcium) Mktg., Sales Practices \u0026 Prods. Liab. Litig.", "to": "In re Bextra \u0026 Celebrex Mktg. Sales Practices \u0026 Prod. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Mallozzi v. Ecosmart Techs., Inc.", "to": "MDL-1760", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Korolshteyn v. Costco Wholesale Corp.", "to": "Mullins v. Premier Nutrition Corp.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Johnson \u0026 Johnson Talcum Powder Prods. Mktg.", "to": "In re Fosamax", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Daniels-Feasel v. Forest Pharms., Inc.", "to": "Rizzo v. Applied Materials, Inc.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Stathakos v. Columbia Sportswear Co.", "to": "Mullins v. Premier Nutrition Corp.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Est. of Warner v. Wellpath", "to": "Bailey v. Nyloncraft, Inc.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Drake v. Allergan", "to": "MDL-1760", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Deepwater Horizon Belo Cases", "to": "In re Zantac (Ranitidine) Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Incretin-Based Therapies Prods. Liab. Litig.", "to": "Cagle v. Cooper Cos.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Moe v. Grinnell College", "to": "Families Advocate, LLC v. Sanford Clinic N.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Behar et al v. Northrup Grumman Corporation", "to": "Patrick v. FirstEnergy Generation Corp.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Newman v. McNeil Consumer Healthcare", "to": "In re Fosamax", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Wagoner v. Exxon Mobil Corp.", "to": "Knight v. Kirby Inland Marine, Inc.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Incretin-Based Therapies Prods. Liab. Litig.", "to": "In re Zoloft (Sertraline Hydrochloride) Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Goodrich v. John Crane Inc.", "to": "Baker v. Chevron USA, Inc.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Ziegler v. Polaris Indus.", "to": "Families Advocate, LLC v. Sanford Clinic N.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Richter v. Syngenta AG (In re Paraquat Prods. Liab. Litig.)", "to": "In re Bextra \u0026 Celebrex Mktg. Sales Practices \u0026 Prod. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Sonner v. Schwabe N. Am., Inc.", "to": "MDL-1629", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Korolshteyn v. Costco Wholesale Corp.", "to": "Sonner v. Schwabe N. Am., Inc.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Richter v. Syngenta AG (In re Paraquat Prods. Liab. Litig.)", "to": "In re Roundup Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Richter v. Syngenta AG (In re Paraquat Prods. Liab. Litig.)", "to": "MDL-2272", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Palmer v. Asarco Inc.", "to": "Knight v. Kirby Inland Marine, Inc.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Gadolinium-Based Contrast Agents Prods. Liab. Litig.", "to": "In re Baycol", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Taxotere (Docetaxel) Prods. Liab. Litig.", "to": "Wagoner v. Exxon Mobil Corp.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Celexa \u0026 Lexapro Prods. Liab. Litig.", "to": "Miller v. Pfizer", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Johnson \u0026 Johnson Talcum Powder Prods. Mktg.", "to": "In re Zoloft (Sertraline Hydrochloride) Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Johnson \u0026 Johnson Talcum Powder Prods. Mktg.", "to": "Magistrini v. One Hour Martinizing Dry Cleaning", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Est. of Warner v. Wellpath", "to": "Glisson v. Corr. Med. Servs.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Mullins v. Premier Nutrition Corp.", "to": "United States v. Bayer Corp.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Sonner v. Schwabe N. Am., Inc.", "to": "Johns v. Bayer Corp.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Gadolinium-Based Contrast Agents Prods. Liab. Litig.", "to": "In re Seroquel", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Roundup Prods. Liab. Litig.", "to": "In re Bextra \u0026 Celebrex Mktg. Sales Practices \u0026 Prod. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Johns v. Bayer Corp.", "to": "In re Bextra \u0026 Celebrex Mktg. Sales Practices \u0026 Prod. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Walls v. Ford Motor Co.", "to": "In re Viagra (Sildenafil Citrate) \u0026 Cialis (Tadalafil)", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Acetaminophen - ASD-ADHD Prods. Liab. Litig.", "to": "In re Zoloft (Sertraline Hydrochloride) Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "MDL-1760", "to": "In re Baycol", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "United States v. Jordan", "to": "Knight v. Kirby Inland Marine, Inc.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Flint Water Cases", "to": "MDL-1760", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Aghaeepour v. N. Leasing Sys.", "to": "Ziegler v. Polaris Indus.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Viagra (Sildenafil Citrate) \u0026 Cialis (Tadalafil)", "to": "Cagle v. Cooper Cos.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Roundup Prods. Liab. Litig.", "to": "In re Seroquel", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Starling v. Banner Health", "to": "Stokes v. John Deere Seeding Group", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Tasigna Nilotinib Prods. Liab. Litig.", "to": "In re Viagra (Sildenafil Citrate) \u0026 Cialis (Tadalafil)", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Glisson v. Corr. Med. Servs.", "to": "Stokes v. John Deere Seeding Group", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Entm\u0027t Software Ass\u0027n v. Hatch", "to": "Video Software Dealers Association v. Schwarzenegger", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Lemberger v. Union Pac. R.R. Co.", "to": "McLaughlin v. BNSF Ry. Co.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Fosamax", "to": "In re Baycol", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Zantac (Ranitidine) Prods. Liab. Litig.", "to": "In re Seroquel", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Richter v. Syngenta AG (In re Paraquat Prods. Liab. Litig.)", "to": "In re Viagra (Sildenafil Citrate) \u0026 Cialis (Tadalafil)", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "MDL-1760", "to": "Baker v. Chevron USA, Inc.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Avandia Mktg.", "to": "Magistrini v. One Hour Martinizing Dry Cleaning", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "MDL-2327", "to": "In re Johnson \u0026 Johnson Talcum Powder Prods. Mktg.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Rizzo v. Applied Materials, Inc.", "to": "In re Fosamax", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Video Software Dealers Association v. Schwarzenegger", "to": "Entm\u0027t Software Ass\u0027n v. Hatch", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Sonner v. Schwabe N. Am., Inc.", "to": "Mullins v. Premier Nutrition Corp.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Johnson \u0026 Johnson Talcum Powder Prods. Mktg.", "to": "In re Testosterone Replacement Therapy Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "MDL-1629", "to": "In re Bextra \u0026 Celebrex Mktg. Sales Practices \u0026 Prod. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Santiago v. Fischer", "to": "In re Fosamax", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Culliver v. BP Expl. \u0026 Prod., Inc.", "to": "Vandestreek v. Lockheed Martin Corp.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Culliver v. BP Expl. \u0026 Prod., Inc.", "to": "Knight v. Kirby Inland Marine, Inc.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Gadolinium-Based Contrast Agents Prods. Liab. Litig.", "to": "In re Fosamax", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "LeBlanc v. Chevron USA Inc.", "to": "Knight v. Kirby Inland Marine, Inc.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Zoloft (Sertraline Hydrochloride) Prods. Liab. Litig.", "to": "In re Lipitor (Atorvastatin Calcium) Mktg., Sales Practices \u0026 Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Dolin v. SmithKline Beecham Corp.", "to": "Tucker v. SmithKline Beecham Corp.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "MDL-1760", "to": "In re Bextra \u0026 Celebrex Mktg. Sales Practices \u0026 Prod. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Richter v. Syngenta AG (In re Paraquat Prods. Liab. Litig.)", "to": "In re Zantac (Ranitidine) Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Whole Woman\u0027s Health Alliance v. Rokita", "to": "Bristol v. Slatery", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Davis v. McKesson Corp.", "to": "In re Zoloft (Sertraline Hydrochloride) Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Mallozzi v. Ecosmart Techs., Inc.", "to": "In re Fosamax", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Daniels-Feasel v. Forest Pharms., Inc.", "to": "In re Fosamax", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Santiago v. Fischer", "to": "Stokes v. John Deere Seeding Group", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Seroquel", "to": "In re Bextra \u0026 Celebrex Mktg. Sales Practices \u0026 Prod. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Johnson \u0026 Johnson Talcum Powder Prods. Mktg.", "to": "MDL-1760", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Miller v. Pfizer", "to": "Magistrini v. One Hour Martinizing Dry Cleaning", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Bextra \u0026 Celebrex Mktg. Sales Practices \u0026 Prod. Liab. Litig.", "to": "Cagle v. Cooper Cos.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Drake v. Allergan", "to": "In re Fosamax", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Proton-Pump Inhibitor Prods. Liab. Litig.", "to": "In re Fosamax", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Korolshteyn v. Costco Wholesale Corp.", "to": "Johns v. Bayer Corp.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Testosterone Replacement Therapy Prods. Liab. Litig.", "to": "In re Actos Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Santiago v. Fischer", "to": "Glisson v. Corr. Med. Servs.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Davis v. McKesson Corp.", "to": "In re Fosamax", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Deepwater Horizon Belo Cases", "to": "Vandestreek v. Lockheed Martin Corp.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Deepwater Horizon Belo Cases", "to": "Knight v. Kirby Inland Marine, Inc.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Video Software Dealers Association v. Schwarzenegger", "to": "Entm\u0027t Software Ass\u0027n v. Blagojevich", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Richter v. Syngenta AG (In re Paraquat Prods. Liab. Litig.)", "to": "In re Zoloft (Sertraline Hydrochloride) Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Richter v. Syngenta AG (In re Paraquat Prods. Liab. Litig.)", "to": "Magistrini v. One Hour Martinizing Dry Cleaning", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "McWilliams v. Novartis AG", "to": "In re Bextra \u0026 Celebrex Mktg. Sales Practices \u0026 Prod. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Sentius Int\u0027l, LLC v. Microsoft Corp.", "to": "Patrick v. FirstEnergy Generation Corp.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Ziegler v. Polaris Indus.", "to": "Santiago v. Fischer", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Onglyza (Saxagliptin) \u0026 Kombiglyze XR (Saxagliptin \u0026 Metformin) Prods. Liab. Litig.", "to": "In re Bextra \u0026 Celebrex Mktg. Sales Practices \u0026 Prod. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Stokes v. John Deere Seeding Group", "to": "Bailey v. Nyloncraft, Inc.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Incretin-Based Therapies Prods. Liab. Litig.", "to": "In re Bextra \u0026 Celebrex Mktg. Sales Practices \u0026 Prod. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "MDL-2327", "to": "Knight v. Kirby Inland Marine, Inc.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Richter v. Syngenta AG (In re Paraquat Prods. Liab. Litig.)", "to": "In re Acetaminophen - ASD-ADHD Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Davis v. McKesson Corp.", "to": "In re Gadolinium-Based Contrast Agents Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Richter v. Syngenta AG (In re Paraquat Prods. Liab. Litig.)", "to": "MDL-1760", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Roundup Prods. Liab. Litig.", "to": "Cagle v. Cooper Cos.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Johns v. Bayer Corp.", "to": "Cagle v. Cooper Cos.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Stathakos v. Columbia Sportswear Co.", "to": "In re Bextra \u0026 Celebrex Mktg. Sales Practices \u0026 Prod. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "MDL-2327", "to": "Davis v. McKesson Corp.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Daniels-Feasel v. Forest Pharms., Inc.", "to": "In re Zoloft (Sertraline Hydrochloride) Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Acetaminophen - ASD-ADHD Prods. Liab. Litig.", "to": "Daniels-Feasel v. Forest Pharms., Inc.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Roundup Prods. Liab. Litig.", "to": "In re Zoloft (Sertraline Hydrochloride) Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Nat\u0027l Prescription Opiate Litig.", "to": "In re Gadolinium-Based Contrast Agents Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Baker v. Chevron USA, Inc.", "to": "Knight v. Kirby Inland Marine, Inc.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Celexa \u0026 Lexapro Prods. Liab. Litig.", "to": "Tucker v. SmithKline Beecham Corp.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Johnson \u0026 Johnson Talcum Powder Prods. Mktg.", "to": "In re Roundup Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Proton-Pump Inhibitor Prods. Liab. Litig.", "to": "In re Zoloft (Sertraline Hydrochloride) Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Proton-Pump Inhibitor Prods. Liab. Litig.", "to": "Magistrini v. One Hour Martinizing Dry Cleaning", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Zantac (Ranitidine) Prods. Liab. Litig.", "to": "Magistrini v. One Hour Martinizing Dry Cleaning", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Zantac (Ranitidine) Prods. Liab. Litig.", "to": "In re Zoloft (Sertraline Hydrochloride) Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Zarling v. Abbott Labs", "to": "Moe v. Grinnell College", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Cook Med., Inc.", "to": "MDL-2272", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Richter v. Syngenta AG (In re Paraquat Prods. Liab. Litig.)", "to": "Daniels-Feasel v. Forest Pharms., Inc.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Proton-Pump Inhibitor Prods. Liab. Litig.", "to": "MDL-1760", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "MDL-1760", "to": "In re Fosamax", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Zoloft (Sertraline Hydrochloride) Prods. Liab. Litig.", "to": "Magistrini v. One Hour Martinizing Dry Cleaning", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Mullins v. Premier Nutrition Corp.", "to": "MDL-1629", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Entm\u0027t Software Ass\u0027n v. Hatch", "to": "Entm\u0027t Software Ass\u0027n v. Blagojevich", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Proton-Pump Inhibitor Prods. Liab. Litig.", "to": "In re Incretin-Based Therapies Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Oliver v. Am. Express Co.", "to": "In re Zoloft (Sertraline Hydrochloride) Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Tasigna Nilotinib Prods. Liab. Litig.", "to": "In re Bextra \u0026 Celebrex Mktg. Sales Practices \u0026 Prod. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Incretin-Based Therapies Prods. Liab. Litig.", "to": "In re Viagra (Sildenafil Citrate) \u0026 Cialis (Tadalafil)", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Testosterone Replacement Therapy Prods. Liab. Litig.", "to": "In re Gadolinium-Based Contrast Agents Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Viagra (Sildenafil Citrate) \u0026 Cialis (Tadalafil)", "to": "In re Roundup Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "MDL-2327", "to": "In re Avandia Mktg.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Ziegler v. Polaris Indus.", "to": "Stokes v. John Deere Seeding Group", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Proton-Pump Inhibitor Prods. Liab. Litig.", "to": "In re Johnson \u0026 Johnson Talcum Powder Prods. Mktg.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "MDL-1760", "to": "In re Gadolinium-Based Contrast Agents Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Zantac (Ranitidine) Prods. Liab. Litig.", "to": "In re Johnson \u0026 Johnson Talcum Powder Prods. Mktg.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Hasemann v. Gerber Prods. Co.", "to": "In re Fosamax", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Aghaeepour v. N. Leasing Sys.", "to": "Stokes v. John Deere Seeding Group", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Johnson \u0026 Johnson Talcum Powder Prods. Mktg.", "to": "Miller v. Pfizer", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Lewert v. Boiron", "to": "Cagle v. Cooper Cos.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Culliver v. BP Expl. \u0026 Prod., Inc.", "to": "In re Zantac (Ranitidine) Prods. Liab. Litig.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "Barrera v. Pharmavite", "to": "Johns v. Bayer Corp.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "In re Testosterone Replacement Therapy Prods. Liab. Litig.", "to": "Tucker v. SmithKline Beecham Corp.", "width": 1}, {"arrows": "to", "color": {"color": "#848484", "opacity": 0.6}, "from": "MDL-1760", "to": "Cagle v. Cooper Cos.", "width": 1}]);

                  nodeColors = {};
                  allNodes = nodes.get({ returnType: "Object" });
                  for (nodeId in allNodes) {
                    nodeColors[nodeId] = allNodes[nodeId].color;
                  }
                  allEdges = edges.get({ returnType: "Object" });
                  // adding nodes and edges to the graph
                  data = {nodes: nodes, edges: edges};

                  var options = {"physics": {"enabled": true, "forceAtlas2Based": {"gravitationalConstant": -50, "centralGravity": 0.01, "springConstant": 0.08, "springLength": 100, "damping": 0.4, "avoidOverlap": 1}, "maxVelocity": 50, "solver": "forceAtlas2Based", "timestep": 0.35, "stabilization": {"iterations": 250}}};

                  


                  

                  network = new vis.Network(container, data, options);

                  

                  

                  


                  
                      network.on("stabilizationProgress", function(params) {
                          document.getElementById('loadingBar').removeAttribute("style");
                          var maxWidth = 496;
                          var minWidth = 20;
                          var widthFactor = params.iterations/params.total;
                          var width = Math.max(minWidth,maxWidth * widthFactor);
                          document.getElementById('bar').style.width = width + 'px';
                          document.getElementById('text').innerHTML = Math.round(widthFactor*100) + '%';
                      });
                      network.once("stabilizationIterationsDone", function() {
                          document.getElementById('text').innerHTML = '100%';
                          document.getElementById('bar').style.width = '496px';
                          document.getElementById('loadingBar').style.opacity = 0;
                          // really clean the dom element
                          setTimeout(function () {document.getElementById('loadingBar').style.display = 'none';}, 500);
                      });
                  

                  return network;

              }
              drawGraph();
        </script>
    </div>
        <style>
        .card { position: relative !important; width: 100% !important; height: 100% !important; margin: 0 !important; border: none !important; border-radius: 0 !important; }
        #mynetwork { width: 100% !important; height: 100% !important; border: none !important; position: absolute !important; top: 0 !important; left: 0 !important; }
        center { display: none !important; }
        center h1 { display: none !important; }
        h1:empty { display: none !important; }
        </style>
        </body>
</html>